<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:08:57Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9250303" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9250303</identifier>
        <datestamp>2022-07-05</datestamp>
        <setSpec>jcem</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Clin Endocrinol Metab</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Clin Endocrinol Metab</journal-id>
              <journal-id journal-id-type="publisher-id">jcem</journal-id>
              <journal-title-group>
                <journal-title>The Journal of Clinical Endocrinology and Metabolism</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0021-972X</issn>
              <issn pub-type="epub">1945-7197</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
                <publisher-loc>US</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9250303</article-id>
              <article-id pub-id-type="pmcid">PMC9250303</article-id>
              <article-id pub-id-type="pmc-uid">9250303</article-id>
              <article-id pub-id-type="pmid">35325161</article-id>
              <article-id pub-id-type="pmid">35325161</article-id>
              <article-id pub-id-type="doi">10.1210/clinem/dgac182</article-id>
              <article-id pub-id-type="publisher-id">dgac182</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Online Only Articles</subject>
                  <subj-group subj-group-type="category-toc-heading">
                    <subject>Clinical Research Article</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00250</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Quinine Effects on Gut and Pancreatic Hormones and Antropyloroduodenal Pressures in Humans–Role of Delivery Site and Sex</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rezaie</surname>
                    <given-names>Peyman</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bitarafan</surname>
                    <given-names>Vida</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rose</surname>
                    <given-names>Braden D</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lange</surname>
                    <given-names>Kylie</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rehfeld</surname>
                    <given-names>Jens F</given-names>
                  </name>
                  <aff><institution>Department of Clinical Biochemistry</institution>, <addr-line>Rigshospitalet, 2100 Copenhagen</addr-line>, <country country="DK">Denmark</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0942-0306</contrib-id>
                  <name>
                    <surname>Horowitz</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                  <aff><institution>Endocrine and Metabolic Unit, Royal Adelaide Hospital</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6848-0125</contrib-id>
                  <name>
                    <surname>Feinle-Bisset</surname>
                    <given-names>Christine</given-names>
                  </name>
                  <aff><institution>Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide</institution>, <addr-line>Adelaide SA 5005</addr-line>, <country country="AU">Australia</country></aff>
                  <xref rid="c1" ref-type="corresp"/>
                  <!--christine.feinle@adelaide.edu.au-->
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="c1"><bold>Correspondence</bold>: Prof Christine Feinle-Bisset, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Corner of North Tce and George St, Adelaide SA 5005, Australia. Email: <email>christine.feinle@adelaide.edu.au</email>.</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2022-03-24">
                <day>24</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>24</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <volume>107</volume>
              <issue>7</issue>
              <fpage>e2870</fpage>
              <lpage>e2881</lpage>
              <history>
                <date date-type="received">
                  <day>03</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
                <date date-type="editorial-decision">
                  <day>20</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="corrected-typeset">
                  <day>13</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="dgac182.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="s1">
                  <title>Context</title>
                  <p>The bitter substance quinine modulates the release of a number of gut and gluco-regulatory hormones and upper gut motility. As the density of bitter receptors may be higher in the duodenum than the stomach, direct delivery to the duodenum may be more potent in stimulating these functions. The gastrointestinal responses to bitter compounds may also be modified by sex.</p>
                </sec>
                <sec id="s2">
                  <title>Background</title>
                  <p>We have characterized the effects of intragastric (IG) versus intraduodenal (ID) administration of quinine hydrochloride (QHCl) on gut and pancreatic hormones and antropyloroduodenal pressures in healthy men and women.</p>
                </sec>
                <sec id="s3">
                  <title>Methods</title>
                  <p>14 men (26 ± 2 years, BMI: 22.2 ± 0.5 kg/m<sup>2</sup>) and 14 women (28 ± 2 years, BMI: 22.5 ± 0.5 kg/m<sup>2</sup>) received 600 mg QHCl on 2 separate occasions, IG or ID as a 10-mL bolus, in randomized, double-blind fashion. Plasma ghrelin, cholecystokinin, peptide YY, glucagon-like peptide-1 (GLP-1), insulin, glucagon, and glucose concentrations and antropyloroduodenal pressures were measured at baseline and for 120 minutes following QHCl.</p>
                </sec>
                <sec id="s4">
                  <title>Results</title>
                  <p>Suppression of ghrelin (<italic toggle="yes">P</italic> = 0.006), stimulation of cholecystokinin (<italic toggle="yes">P</italic> = 0.030), peptide YY (<italic toggle="yes">P</italic> = 0.017), GLP-1 (<italic toggle="yes">P</italic> = 0.034), insulin (<italic toggle="yes">P</italic> = 0.024), glucagon (<italic toggle="yes">P</italic> = 0.030), and pyloric pressures (<italic toggle="yes">P</italic> = 0.050), and lowering of glucose (<italic toggle="yes">P</italic> = 0.001) were greater after ID-QHCl than IG-QHCl. Insulin stimulation (<italic toggle="yes">P</italic> = 0.021) and glucose reduction (<italic toggle="yes">P</italic> = 0.001) were greater in females than males, while no sex-associated effects were found for cholecystokinin, peptide YY, GLP-1, glucagon, or pyloric pressures.</p>
                </sec>
                <sec id="s5">
                  <title>Conclusion</title>
                  <p>ID quinine has greater effects on plasma gut and pancreatic hormones and pyloric pressures than IG quinine in healthy subjects, consistent with the concept that stimulation of small intestinal bitter receptors is critical to these responses. Both insulin stimulation and glucose lowering were sex-dependent.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>gut functions</kwd>
                <kwd>bitter taste</kwd>
                <kwd>appetite-regulatory hormones</kwd>
                <kwd>glucoregulatory hormones</kwd>
                <kwd>gut motility</kwd>
                <kwd>human</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Adelaide Scholarship International</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>University of Adelaide</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100001786</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>2017-2020</award-id>
                  <award-id>P.R., 2018–2022</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Health and Medical Research Council</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100000925</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1158296</award-id>
                  <award-id>2019–2022</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Senior Research Fellowship</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1103020</award-id>
                  <award-id>2016–2022</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="12"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>There is increasing interest in the gastrointestinal (GI) effects of bitter substances, stimulated by preclinical observations that a number of bitter compounds have potent effects to modulate gut and glucoregulatory hormones (e.g., cholecystokinin [CCK], glucagon-like peptide [GLP-1]) as well as upper GI motility, which underlies the slowing of gastric meal emptying (<xref rid="CIT0001" ref-type="bibr">1-4</xref>). This is of particular interest, because, as both GI hormones and gastric emptying contribute to the regulation of energy intake and postprandial blood glucose (<xref rid="CIT0005" ref-type="bibr">5</xref>), there are substantial implications for the management of obesity and type 2 diabetes.</p>
            <p>Bitter substances are sensed in the GI lumen by bitter taste receptors, located on enteroendocrine cells (<xref rid="CIT0006" ref-type="bibr">6</xref>). In both cell lines and experimental animals, a number of bitter agonists have been shown to potently stimulate gut hormones, particularly ghrelin, CCK, and GLP-1 (<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0007" ref-type="bibr">7-9</xref>). Some bitter substances have also been found to slow gastric emptying (<xref rid="CIT0001" ref-type="bibr">1</xref>), possibly reflecting direct effects on smooth muscle contractility (<xref rid="CIT0001" ref-type="bibr">1</xref>). These preclinical observations have attracted recent interest to establish whether they can be replicated in humans and, if so, whether they are associated with reductions in energy intake and/or blood glucose (<xref rid="CIT0005" ref-type="bibr">5</xref>). Quinine is probably the best-studied bitter substance in humans. It is used clinically to treat malaria, usually in a dose of 500 mg intravenously (<xref rid="CIT0010" ref-type="bibr">10</xref>), and has the capacity to induce hypoglycemia, probably by direct stimulation of insulin (<xref rid="CIT0011" ref-type="bibr">11</xref>). A small number of studies have reported effects of quinine on the secretion of gut hormones, including suppression of plasma ghrelin, and stimulation of CCK and GLP-1 (<xref rid="CIT0012" ref-type="bibr">12-16</xref>). Intragastric (IG) administration of quinine hydrochloride (QHCl), in a dose of 10 µmol/kg (equivalent to ~270 mg in a 70-kg human), suppressed ghrelin (<xref rid="CIT0014" ref-type="bibr">14</xref>, <xref rid="CIT0015" ref-type="bibr">15</xref>), while a recent study from the same group found no effect of either intraduodenal (ID) or IG-QHCl, in the same dose, on plasma CCK (<xref rid="CIT0017" ref-type="bibr">17</xref>). In contrast, an IG bolus of 18 mg QHCl was found to increase plasma CCK (although the effect was very small) after a standardized meal (<xref rid="CIT0012" ref-type="bibr">12</xref>). Both ID- and IG-QHCl, in a dose of 600 mg (~500 mg quinine), stimulated GLP-1 and insulin, associated with postprandial blood glucose lowering (<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0016" ref-type="bibr">16</xref>). The effect of quinine on peptide YY (PYY) is not known.</p>
            <p>Animal studies indicate that the density of bitter taste receptors is greater in the duodenum than the stomach (<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0018" ref-type="bibr">18</xref>), suggesting that ID administration may have more potent effects than IG delivery to modulate GI hormones and motility. Indeed, in our recent studies, QHCl, in a dose of 600 mg, administered either ID 30 minutes before, or IG 60 minutes (to allow time for small intestinal exposure) before, a mixed-nutrient drink, had comparable effects to slow gastric emptying (<xref rid="CIT0016" ref-type="bibr">16</xref>), while IG administration 30 minutes before the drink had no effect (<xref rid="CIT0013" ref-type="bibr">13</xref>). The comparative effects of ID and IG quinine on the release of gut (ie, ghrelin, CCK, PYY, GLP-1) and pancreatic (ie, insulin, glucagon) hormones and upper GI motility in humans have not been evaluated.</p>
            <p>Oral sensitivity to bitter substances may be higher in women than men, as reflected in lower detection thresholds for the bitter substance, 6-n-propylthiouracil (<xref rid="CIT0019" ref-type="bibr">19</xref>). That their response to GI exposure may also be enhanced, is supported by a report that IG administration of denatonium benzoate affected the origin of phase III of fasting motility and decreased hunger and energy intake in women, but not men (<xref rid="CIT0020" ref-type="bibr">20</xref>). Whether there are sex differences in the effects of bitter substances on gut and pancreatic hormone secretion, or the changes in upper GI motility that underlie the slowing of gastric emptying, is not known.</p>
            <p>The aims of this study were to determine the effects of the site of administration, that is, stomach or duodenum, of the bitter substance QHCl on gut and pancreatic hormones and antropyloroduodenal pressures in healthy individuals and to evaluate whether any effects are influenced by sex.</p>
            <sec sec-type="materials" id="s6">
              <title>Methods</title>
              <sec id="s7">
                <title>Study Participants</title>
                <p>14 healthy males (mean age: 26 ± 2 years, body mass index [BMI]: 22.2 ± 0.5 kg/m<sup>2</sup>) and 14 healthy premenopausal females (mean age: 28 ± 1.9 years, BMI: 22.5 ± 0.5 kg/m<sup>2</sup>) participated in the study. Because of a lack of suitable prior data, we were unable to perform power calculations. However, based on our recent studies, we calculated that n = 14 participants would allow detection of a difference of 5 pmol/L, with an SD of 6 pmol/L, for plasma GLP-1 (<xref rid="CIT0016" ref-type="bibr">16</xref>), and a difference of 15, with a SD of 14, for the number of pyloric pressure waves (<xref rid="CIT0021" ref-type="bibr">21</xref>), at α = 0.05 and a power of 80%. Participants were recruited through flyers placed around local universities and the Royal Adelaide Hospital, and advertisements in local newspapers. Each was screened before their inclusion to exclude those with GI symptoms or a history of GI disease or surgery; vegetarians; smokers; overweight or obese individuals (BMI &gt; 25 kg/m<sup>2</sup>); an alcohol consumption of &gt; 20 g/day on &gt; 5 days/week; use of medications known to affect appetite, energy intake, or GI function; high-performance athletes; unstable body weight (≥5% change over the last 3 months before participation); and restrained eaters (score &gt; 12 on the restrained eating component of the 3-factor eating questionnaire) (<xref rid="CIT0022" ref-type="bibr">22</xref>). Oral taste detection thresholds for QHCl were quantified, using the ascending-series 3-alternative forced-choice technique (<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0023" ref-type="bibr">23</xref>), to ensure that all participants detected QHCl. The study protocol was approved by The Human Research Ethics Committee of the Central Adelaide Local Health Network and performed in accordance with the Declaration of Helsinki. All participants provided written, informed consent before their inclusion, and after enrollment each was assigned to a treatment order of balanced randomization that was generated with an online tool (<ext-link xlink:href="http://www.randomization.com" ext-link-type="uri">www.randomization.com</ext-link>) by a research officer who was not involved in data analysis. The study was registered as a clinical trial with the Australian and New Zealand Clinical Trials Registry (<ext-link xlink:href="http://www.anzctr.org.au" ext-link-type="uri">www.anzctr.org.au</ext-link>; ACTRN12619000707167) and performed from May 2019 to August 2020.</p>
              </sec>
              <sec id="s8">
                <title>Study Outline</title>
                <p>The study evaluated the effects of IG and ID administration of QHCl, in a dose of 600 mg, on gut (ie, ghrelin, CCK, PYY, GLP-1) and pancreatic (ie, insulin and glucagon) hormones and antropyloroduodenal pressures in healthy lean men and women. Plasma glucose was also measured, primarily to ensure that concentrations remained within physiological levels. Hormone concentrations and antropyloroduodenal pressures were primary, while plasma glucose and GI symptoms were secondary, outcomes. We employed intragastric and intraduodenal administration to ensure standardized and targeted delivery of QHCl to the desired site.</p>
              </sec>
              <sec id="s9">
                <title>Preparation of QHCl Solution</title>
                <p>The QHCl solution was prepared by dissolving 600 mg QHCl (Sinkona Indonesia Lestari, Subang, West Java, Indonesia) in 10 mL distilled water. The solution was prepared on the morning of each study day, and filled in a syringe, by a research officer who had no involvement in data analysis, and administered at a temperature of ~30 °C. The dose of QHCl was chosen based on our previous study, in which ID and IG administration of 600 mg QHCl were shown to stimulate GLP-1, slow gastric emptying, and reduce postprandial blood glucose (<xref rid="CIT0016" ref-type="bibr">16</xref>).</p>
              </sec>
              <sec id="s10">
                <title>Study Protocol</title>
                <p>Each participant was studied on 2 occasions, separated by 3 to 7 days, in randomized, double-blind fashion. Studies in women were performed during the follicular phase of their menstrual cycle (ie, days 1-8) to minimize a potential confounding effect (<xref rid="CIT0024" ref-type="bibr">24</xref>). Participants were instructed to refrain from vigorous physical activity and alcohol consumption for 24 hours prior to each study and, were provided with a standardized meal (beef lasagna; total energy content: 602 kcal; McCain Food, Wendouree, Victoria, Australia) to be consumed between 6:30 and 7 <sc>pm</sc> on the evening prior to each study visit. The following morning, each participant attended the Clinical Research Facility at the Adelaide Medical School, University of Adelaide, at 8:15 <sc>am</sc> after an overnight fast (from both solids and liquids, with the exception of water, after 7 <sc>pm</sc>, and from water after 6.30 <sc>am</sc>).</p>
                <p>Upon arrival, each participant was intubated with a manometric catheter (Dentsleeve International, Mui Scientific, Mississauga, Ontario, Canada; total length: 100 cm; external diameter: 3.5 mm), which was inserted through an anesthetized nostril into the stomach and allowed to pass into the duodenum by peristalsis. The catheter included 6 channels positioned in the antrum, a 4.5-cm pyloric sleeve sensor with 2 channels situated on its back, and 7 channels positioned in the duodenum, with all side-holes spaced at 1.5-cm intervals, measuring pressures in the antrum, pylorus, and duodenum (<xref rid="CIT0025" ref-type="bibr">25</xref>). The correct positioning of the catheter, with the sleeve sensor straddling the pylorus, was maintained by continuous measurement of the transmucosal potential difference between the most distal antral, and most proximal duodenal, channels (<xref rid="CIT0026" ref-type="bibr">26</xref>). The most proximal antral channel was used for IG administration of quinine, and an additional infusion channel, located ~14.5 cm distal to the pylorus, for ID administration.</p>
                <p>Once the catheter was in position (within 55 ± 10 min), an intravenous cannula was placed into a forearm vein, and the arm was kept warm with a heat pad for regular sampling of “arterialized” blood. Following the occurrence of phase III of fasting motility (a distinct motor pattern characterized by high-frequency, high-amplitude contractions designed to clear the GI lumen of food remnants), during phase I (a period of motor quiescence), fasting motility was monitored for 10 minutes (t = −10 to 0 minutes), and at t = −1 minute, QHCl was administered, within 1 minute, into either the stomach or duodenum. Blood samples were taken at baseline (t = −10 minutes) and following quinine administration, at t = 0, 10, 20, 30, 45, 60, 75, 90, and 120 minutes, for measurement of plasma concentrations of ghrelin, CCK, PYY, GLP-1, insulin, glucagon, and glucose. Visual analog scale (VAS) ratings, to assess GI symptoms, ie, bloating and nausea, were collected at the same time points. Antropyloroduodenal pressures were measured continuously for 120 minutes. At t = 120 minutes, the catheter and the intravenous cannula were removed, each participant was provided with a light lunch and was then free to leave the laboratory.</p>
              </sec>
              <sec id="s11">
                <title>Measurements</title>
                <sec id="s12">
                  <title>Plasma glucose and hormone analyses</title>
                  <p>Blood samples were collected into ice-chilled tubes containing ethylenediaminetetraacetic acid. Plasma was obtained by centrifuging samples at ~1832<italic toggle="yes">g</italic> force for 15 minutes at 4 °C within 15 minutes of collection and stored at −80 °C until subsequent analysis. Because “total” hormone concentrations were measured, the addition of a protease inhibitor was not required.</p>
                  <p>Plasma ghrelin concentrations (pg/mL) were measured by an in-house radioimmunoassay using an antibody purchased from Peninsula Laboratories (Cat# T-4745, RRID: AB_518360). The minimum detectable concentration was 40 pg/mL, intra- and interassay coefficients of variation (CVs) were 8.2% and 10.6%, respectively.</p>
                  <p>Plasma CCK concentrations (pmol/L) were measured by an in-house radioimmunoassay, developed by Prof Rehfeld, using an antiserum (Cat# 92128, RRID: AB_2893008), which binds the circulating bioactive forms of CCK with equal potency, and without cross-reactivity with homologous gastrin peptides (<xref rid="CIT0027" ref-type="bibr">27</xref>). The minimum detectable concentration was 0.1 pmol/L, and intra- and interassay CVs were 5% and 15%, respectively.</p>
                  <p>Plasma PYY concentrations (pmol/L) were measured by an in-house radioimmunoassay using an antiserum against human PYY (<xref rid="CIT0001" ref-type="bibr">1-36</xref>), kindly donated by Dr Bärbel Otto, Ludwig-Maximilians-Universität, Munich, Germany (Cat# PYY, RRID: AB_2895649) (<xref rid="CIT0028" ref-type="bibr">28</xref>). The minimum detectable concentration was 1.5 pmol/L, and intra- and interassay CVs were 7.9% and 12.9%, respectively.</p>
                  <p>Plasma total GLP-1 concentrations (pmol/L) were measured by a commercial radioimmunoassay (Millipore Cat# GLPIT-36HK, RRID: AB_2757816). The minimum detectable concentration was 3 pmol/L, and intra- and interassay CVs were 6.9% and 10.9%, respectively.</p>
                  <p>Plasma insulin concentrations (mU/L) were measured by a commercial ELISA immunoassay (Mercodia Cat# 10-1113, RRID: AB_2877672). The sensitivity of the assay was 1.0 mU/L, and intra- and interassay CVs were 2.9% and 11.6%, respectively.</p>
                  <p>Plasma glucagon concentrations (pg/mL) were measured by a commercial radioimmunoassay (Millipore Cat# GL-32K, RRID: AB_2757819). The minimum detectable concentration was 15 pg/mL, and intra- and interassay CVs were 3.8% and 9.3%, respectively.</p>
                  <p>Plasma glucose concentrations (mmol/L) were measured by the glucose oxidase method, using a glucose analyzer (YSI 2300 Stat Plus, Yellow Springs Instruments, Yellow Springs, OH).</p>
                </sec>
                <sec id="s13">
                  <title>Antropyloroduodenal pressures</title>
                  <p>Antropyloroduodenal pressures were digitized and recorded using a computer-based system running commercially available software (MMS Data base software, version 8.17; Solar GI). Data were analyzed for the number and amplitude of antral and duodenal pressures, and isolated pyloric pressure waves (IPPWs) using custom-written software modified to our requirements (A Smout, University Medical Centre, Amsterdam, Netherlands) as described (<xref rid="CIT0029" ref-type="bibr">29</xref>). Antral pressure waves and IPPWs were defined by an amplitude of ≥ 10 mmHg with a minimum interval of 10 seconds between peaks. Duodenal pressure waves were defined by an amplitude of ≥ 10 mmHg with a minimum of 3 seconds between peaks (<xref rid="CIT0030" ref-type="bibr">30</xref>).</p>
                </sec>
                <sec id="s14">
                  <title>GI symptoms</title>
                  <p>Bloating and nausea were evaluated using a VAS questionnaire (<xref rid="CIT0021" ref-type="bibr">21</xref>). The strength of each perception was rated on a 100-mm horizontal line, where 0 mm represented “sensation not felt at all” and 100 mm “sensation felt the greatest”. Subjects were asked to indicate how they were feeling at each time point by placing a vertical mark on the line.</p>
                </sec>
              </sec>
              <sec id="s15">
                <title>Data and Statistical Analysis</title>
                <p>Statistical analysis was performed using SPSS software (version 27.0; IBM, Chicago, IL, USA).</p>
                <p>Plasma CCK, PYY, GLP-1, insulin, glucagon, and VAS data were summarized by areas under the curve (AUC), and ghrelin and glucose data, whose concentrations, in contrast to the above hormones, were anticipated to be reduced by administration of quinine, using inverted incremental AUC (iAUCinv), calculated using the trapezoidal rule. Numbers and amplitudes of antral and duodenal pressure waves were used to calculate antral and duodenal motility indexes (MIs), using the following equation: MI (mmHg) = natural logarithm {[sum of amplitudes × number of pressure waves] + 1} (<xref rid="CIT0031" ref-type="bibr">31</xref>). Numbers and amplitudes of IPPWs were expressed as total numbers and mean amplitudes, respectively. All data were summarized for both the entire study period, namely, AUC<sub>0-120</sub>, MI<sub>0-120</sub>, and number/amplitude<sub>0-120</sub>, as well as for the first 60 minutes, namely, AUC<sub>0-60</sub>, etc, and for the second 60 minutes, namely, AUC<sub>60-120</sub>, etc, to evaluate whether effects were evident predominantly “earlier” or “later”, based on our previous findings (<xref rid="CIT0032" ref-type="bibr">32-34</xref>). We also determined peak values, as well as times to peak values, for plasma CCK and insulin concentrations, and the number of IPPWs. These were not calculated for other parameters, given that it was shown subsequently that these did not reach a peak (or nadir, in the case of ghrelin), but continued to rise (or fall), throughout the study period.</p>
                <p>One-way analysis of variance (ANOVA) was used to evaluate effects of treatments over time relative to baseline. In order to evaluate the potential effects of both site of administration and sex, data were analyzed using mixed effects maximum likelihood models with visit number (1 or 2), site of administration, sex, and the site-by-sex interaction as fixed factors, and a random subject effect. An unstructured covariance matrix was used to account for the repeated visits per subject. Prespecified contrasts of the model-estimated marginal means were calculated for the 4 primary comparisons of interest: male ID vs male IG, female ID vs female IG, female ID vs male ID, female IG vs male IG. No adjustments for multiple comparisons were made, because the 4 contrasts were prespecified (ie, before examination of the data) to correspond to the primary research hypotheses. They were interpreted independently, regardless of the significance of the other contrasts or the significance of the overall effects from the mixed models. All data are reported as mean ± standard error of the mean (SEM).</p>
              </sec>
            </sec>
            <sec id="s16">
              <title>Results</title>
              <p>The QHCl treatments were well tolerated, and all participants completed the study visits without reporting any adverse effect. Oral detection thresholds for QHCl were 0.10 ± 0.07 mmol/L in males, and 0.10 ± 0.02 mmol/L in females, with no difference between the 2 groups. No participant experienced hypoglycemia in response to QHCl, and glucose concentrations remained above 3.9 mmol/L in all participants. There were no differences in fasting plasma concentrations of gut hormones (<xref rid="T1" ref-type="table">Table 1</xref>), pancreatic hormones and glucose (<xref rid="T2" ref-type="table">Table 2</xref>), or antropyloroduodenal pressures (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
              <table-wrap position="float" id="T1">
                <label>Table 1.</label>
                <caption>
                  <p>Plasma ghrelin, CCK, PYY, and GLP-1 concentrations at baseline and following intragastric or intraduodenal administration of quinine in healthy men and women</p>
                </caption>
                <table frame="vsides" rules="groups">
                  <thead>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th colspan="3" rowspan="1">Male</th>
                      <th colspan="3" rowspan="1">Female</th>
                    </tr>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma ghrelin</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, pg/mL</td>
                      <td rowspan="1" colspan="1">1499 ± 160</td>
                      <td rowspan="1" colspan="1">1560 ± 163</td>
                      <td rowspan="1" colspan="1">0.243</td>
                      <td rowspan="1" colspan="1">1643 ± 214</td>
                      <td rowspan="1" colspan="1">1645 ± 200</td>
                      <td rowspan="1" colspan="1">0.989</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> iAUCinv<sub>0-120min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">5724 ± 5693</td>
                      <td rowspan="1" colspan="1">19894 ± 5276</td>
                      <td rowspan="1" colspan="1">0.006</td>
                      <td rowspan="1" colspan="1">15133 ± 5442</td>
                      <td rowspan="1" colspan="1">28384 ± 5412</td>
                      <td rowspan="1" colspan="1">0.007</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> iAUCinv<sub>0-60min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">2940 ± 1891</td>
                      <td rowspan="1" colspan="1">7550 ± 1739</td>
                      <td rowspan="1" colspan="1">0.019</td>
                      <td rowspan="1" colspan="1">4983 ± 1795</td>
                      <td rowspan="1" colspan="1">9673 ± 1795</td>
                      <td rowspan="1" colspan="1">0.013</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUCinv<sub>60-120min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">2468 ± 4189</td>
                      <td rowspan="1" colspan="1">12197 ± 3873</td>
                      <td rowspan="1" colspan="1">0.010</td>
                      <td rowspan="1" colspan="1">10292 ± 4002</td>
                      <td rowspan="1" colspan="1">19032 ± 4002</td>
                      <td rowspan="1" colspan="1">0.015</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma CCK</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, mmol/L</td>
                      <td rowspan="1" colspan="1">1.0 ± 0.1</td>
                      <td rowspan="1" colspan="1">1.0 ± 0.2</td>
                      <td rowspan="1" colspan="1">0.407</td>
                      <td rowspan="1" colspan="1">0.7 ± 0.2</td>
                      <td rowspan="1" colspan="1">0.7 ± 0.2</td>
                      <td rowspan="1" colspan="1">0.430</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">174 ± 20</td>
                      <td rowspan="1" colspan="1">261 ± 20</td>
                      <td rowspan="1" colspan="1">0.002</td>
                      <td rowspan="1" colspan="1">199 ± 20</td>
                      <td rowspan="1" colspan="1">234 ± 20</td>
                      <td rowspan="1" colspan="1">0.147</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-60min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">85 ± 13</td>
                      <td rowspan="1" colspan="1">148 ± 13</td>
                      <td rowspan="1" colspan="1">0.006</td>
                      <td rowspan="1" colspan="1">105 ± 13</td>
                      <td rowspan="1" colspan="1">151 ± 13</td>
                      <td rowspan="1" colspan="1">0.030</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>60-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">91 ± 9</td>
                      <td rowspan="1" colspan="1">107 ± 9</td>
                      <td rowspan="1" colspan="1">0.134</td>
                      <td rowspan="1" colspan="1">92 ± 9</td>
                      <td rowspan="1" colspan="1">85 ± 9</td>
                      <td rowspan="1" colspan="1">0.538</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Peak concentration, pmol/L</td>
                      <td rowspan="1" colspan="1">2.4 ± 0.4</td>
                      <td rowspan="1" colspan="1">3.8 ± 0.4</td>
                      <td rowspan="1" colspan="1">0.010</td>
                      <td rowspan="1" colspan="1">3.1 ± 0.4</td>
                      <td rowspan="1" colspan="1">4.2 ± 0.4</td>
                      <td rowspan="1" colspan="1">0.050</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Time to peak concentration, min</td>
                      <td rowspan="1" colspan="1">33 ± 5</td>
                      <td rowspan="1" colspan="1">18 ± 5</td>
                      <td rowspan="1" colspan="1">0.020</td>
                      <td rowspan="1" colspan="1">42 ± 5</td>
                      <td rowspan="1" colspan="1">25 ± 5</td>
                      <td rowspan="1" colspan="1">0.010</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma PYY</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, pmol/L</td>
                      <td rowspan="1" colspan="1">32.2 ± 3.6</td>
                      <td rowspan="1" colspan="1">33.9 ± 2.6</td>
                      <td rowspan="1" colspan="1">0.199</td>
                      <td rowspan="1" colspan="1">29.9 ± 3.9</td>
                      <td rowspan="1" colspan="1">29.4 ± 4.3</td>
                      <td rowspan="1" colspan="1">0.920</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">4215 ± 239</td>
                      <td rowspan="1" colspan="1">5068 ± 232</td>
                      <td rowspan="1" colspan="1">0.017</td>
                      <td rowspan="1" colspan="1">3983 ± 235</td>
                      <td rowspan="1" colspan="1">4879 ± 239</td>
                      <td rowspan="1" colspan="1">0.013</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-60min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">1973 ± 102</td>
                      <td rowspan="1" colspan="1">2390 ± 99</td>
                      <td rowspan="1" colspan="1">0.010</td>
                      <td rowspan="1" colspan="1">1902 ± 100</td>
                      <td rowspan="1" colspan="1">2268 ± 101</td>
                      <td rowspan="1" colspan="1">0.022</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>60-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">2242 ± 154</td>
                      <td rowspan="1" colspan="1">2669 ± 149</td>
                      <td rowspan="1" colspan="1">0.048</td>
                      <td rowspan="1" colspan="1">2090 ± 151</td>
                      <td rowspan="1" colspan="1">2609 ± 154</td>
                      <td rowspan="1" colspan="1">0.020</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma GLP-1</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, pmol/L</td>
                      <td rowspan="1" colspan="1">11.5 ± 1.3</td>
                      <td rowspan="1" colspan="1">12.0 ± 1.5</td>
                      <td rowspan="1" colspan="1">0.283</td>
                      <td rowspan="1" colspan="1">9.8 ± 1.10</td>
                      <td rowspan="1" colspan="1">9.7 ± 1.0</td>
                      <td rowspan="1" colspan="1">0.458</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">1480 ± 99</td>
                      <td rowspan="1" colspan="1">1808 ± 99</td>
                      <td rowspan="1" colspan="1">0.025</td>
                      <td rowspan="1" colspan="1">1377 ± 98</td>
                      <td rowspan="1" colspan="1">1685 ± 99</td>
                      <td rowspan="1" colspan="1">0.034</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-60min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">675 ± 43</td>
                      <td rowspan="1" colspan="1">819 ± 43</td>
                      <td rowspan="1" colspan="1">0.028</td>
                      <td rowspan="1" colspan="1">623 ± 43</td>
                      <td rowspan="1" colspan="1">746 ± 43</td>
                      <td rowspan="1" colspan="1">0.054</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>60-120min</sub>, pmol/L × min</td>
                      <td rowspan="1" colspan="1">791 ± 66</td>
                      <td rowspan="1" colspan="1">985 ± 66</td>
                      <td rowspan="1" colspan="1">0.040</td>
                      <td rowspan="1" colspan="1">739 ± 66</td>
                      <td rowspan="1" colspan="1">926 ± 66</td>
                      <td rowspan="1" colspan="1">0.046</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="T1Fn1">
                    <p>Data are means ± SEMs. n = 14 in each group, except for ghrelin (n = 12).</p>
                  </fn>
                  <fn id="T1Fn2">
                    <p>Abbreviations: AUC, area under the curve; CCK, cholecystokinin; GLP-1, glucagon-like peptide-1; iAUCinv, inverted incremental AUC; ID-QHCl, intraduodenal quinine hydrochloride; IG-QHCl, intragastric quinine hydrochloride; PYY, peptide-YY. There were no effects of sex on plasma ghrelin, CCK, PYY, or GLP-1 after either IG-QHCl or ID-QHCl.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <table-wrap position="float" id="T2">
                <label>Table 2.</label>
                <caption>
                  <p>Plasma insulin, glucagon, and glucose concentrations at baseline and following intragastric or intraduodenal administration of quinine in healthy, normal-weight men and women</p>
                </caption>
                <table frame="vsides" rules="groups">
                  <thead>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th colspan="3" rowspan="1">Male</th>
                      <th colspan="3" rowspan="1">Female</th>
                    </tr>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma insulin</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, mU/L</td>
                      <td rowspan="1" colspan="1">2.7 ± 0.5</td>
                      <td rowspan="1" colspan="1">2.4 ± 0.4</td>
                      <td rowspan="1" colspan="1">0.288</td>
                      <td rowspan="1" colspan="1">3.6 ± 0.5</td>
                      <td rowspan="1" colspan="1">3.3 ± 0.2</td>
                      <td rowspan="1" colspan="1">0.463</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-120min</sub>, mU/L × min</td>
                      <td rowspan="1" colspan="1">648 ± 77</td>
                      <td rowspan="1" colspan="1">865 ± 79</td>
                      <td rowspan="1" colspan="1">0.024</td>
                      <td rowspan="1" colspan="1">754 ± 79</td>
                      <td rowspan="1" colspan="1">1042 ± 77</td>
                      <td rowspan="1" colspan="1">0.004</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-60min</sub>, mU/L × min</td>
                      <td rowspan="1" colspan="1">261 ± 52</td>
                      <td rowspan="1" colspan="1">485 ± 53</td>
                      <td rowspan="1" colspan="1">0.006</td>
                      <td rowspan="1" colspan="1">344 ± 53</td>
                      <td rowspan="1" colspan="1">663 ± 52<xref rid="T2Fn4" ref-type="table-fn"><sup>a</sup></xref></td>
                      <td rowspan="1" colspan="1">0.001</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>60-120min</sub>, mU/L × min</td>
                      <td rowspan="1" colspan="1">370 ± 41</td>
                      <td rowspan="1" colspan="1">368 ± 42</td>
                      <td rowspan="1" colspan="1">0.956</td>
                      <td rowspan="1" colspan="1">423 ± 42</td>
                      <td rowspan="1" colspan="1">394 ± 41</td>
                      <td rowspan="1" colspan="1">0.462</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Peak concentration, mU/L</td>
                      <td rowspan="1" colspan="1">8.5 ± 1.5</td>
                      <td rowspan="1" colspan="1">13.2 ± 1.5</td>
                      <td rowspan="1" colspan="1">0.040</td>
                      <td rowspan="1" colspan="1">11.7 ± 1.5</td>
                      <td rowspan="1" colspan="1">19 ± 1.5<xref rid="T2Fn5" ref-type="table-fn"><sup>b</sup></xref></td>
                      <td rowspan="1" colspan="1">0.002</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Time to peak concentration, min</td>
                      <td rowspan="1" colspan="1">71 ± 5</td>
                      <td rowspan="1" colspan="1">39 ± 5</td>
                      <td rowspan="1" colspan="1">0.001</td>
                      <td rowspan="1" colspan="1">60 ± 5</td>
                      <td rowspan="1" colspan="1">39 ± 5</td>
                      <td rowspan="1" colspan="1">0.012</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma glucagon</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, pg/mL</td>
                      <td rowspan="1" colspan="1">41 ± 4</td>
                      <td rowspan="1" colspan="1">43 ± 4</td>
                      <td rowspan="1" colspan="1">0.941</td>
                      <td rowspan="1" colspan="1">40 ± 2</td>
                      <td rowspan="1" colspan="1">41 ± 4</td>
                      <td rowspan="1" colspan="1">0.777</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-120min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">5044 ± 371</td>
                      <td rowspan="1" colspan="1">6189 ± 362</td>
                      <td rowspan="1" colspan="1">0.030</td>
                      <td rowspan="1" colspan="1">5401 ± 362</td>
                      <td rowspan="1" colspan="1">6607 ± 362</td>
                      <td rowspan="1" colspan="1">0.021</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>0-60min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">2193 ± 138</td>
                      <td rowspan="1" colspan="1">2710 ± 139</td>
                      <td rowspan="1" colspan="1">0.023</td>
                      <td rowspan="1" colspan="1">2427 ± 137</td>
                      <td rowspan="1" colspan="1">2800 ± 137</td>
                      <td rowspan="1" colspan="1">0.081</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> AUC<sub>60-120min</sub>, pg/mL × min</td>
                      <td rowspan="1" colspan="1">2842 ± 250</td>
                      <td rowspan="1" colspan="1">3497 ± 244</td>
                      <td rowspan="1" colspan="1">0.043</td>
                      <td rowspan="1" colspan="1">2990 ± 245</td>
                      <td rowspan="1" colspan="1">3780 ± 245</td>
                      <td rowspan="1" colspan="1">0.015</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Plasma glucose</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Fasting concentration, mmol/L</td>
                      <td rowspan="1" colspan="1">4.8 ± 0.1</td>
                      <td rowspan="1" colspan="1">4.5 ± 0.1</td>
                      <td rowspan="1" colspan="1">0.251</td>
                      <td rowspan="1" colspan="1">5.3 ± 0.1</td>
                      <td rowspan="1" colspan="1">5.4 ± 0.1</td>
                      <td rowspan="1" colspan="1">0.487</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> iAUCinv<sub>0-120min</sub>, mmol/L × min</td>
                      <td rowspan="1" colspan="1">57 ± 9</td>
                      <td rowspan="1" colspan="1">58 ± 8</td>
                      <td rowspan="1" colspan="1">0.947</td>
                      <td rowspan="1" colspan="1">50 ± 8</td>
                      <td rowspan="1" colspan="1">99 ± 8<xref rid="T2Fn6" ref-type="table-fn"><sup>c</sup></xref></td>
                      <td rowspan="1" colspan="1">0.001</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> iAUCinv<sub>0-60min</sub>, mmol/L × min</td>
                      <td rowspan="1" colspan="1">21 ± 4</td>
                      <td rowspan="1" colspan="1">25 ± 4</td>
                      <td rowspan="1" colspan="1">0.505</td>
                      <td rowspan="1" colspan="1">9 ± 4<xref rid="T2Fn7" ref-type="table-fn"><sup>d</sup></xref></td>
                      <td rowspan="1" colspan="1">39 ± 4<xref rid="T2Fn8" ref-type="table-fn"><sup>e</sup></xref></td>
                      <td rowspan="1" colspan="1">0.001</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> iAUCinv<sub>60-120min</sub>, mmol/L × min</td>
                      <td rowspan="1" colspan="1">36 ± 6</td>
                      <td rowspan="1" colspan="1">33 ± 6</td>
                      <td rowspan="1" colspan="1">0.634</td>
                      <td rowspan="1" colspan="1">41 ± 6</td>
                      <td rowspan="1" colspan="1">59 ± 6<xref rid="T2Fn9" ref-type="table-fn"><sup>f</sup></xref></td>
                      <td rowspan="1" colspan="1">0.036</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="T2Fn1">
                    <p>Data are means ± SEMs. n = 14 in each group, except for glucagon (n = 12).</p>
                  </fn>
                  <fn id="T2Fn2">
                    <p>Abbreviations: AUC, area under the curve; iAUCinv, inverted incremental AUC; ID-QHCl, intraduodenal quinine hydrochloride; IG-QHCl, intragastric quinine hydrochloride.</p>
                  </fn>
                  <fn id="T2Fn3">
                    <p>Differences from respective values in males:</p>
                  </fn>
                  <fn id="T2Fn4">
                    <p><sup>a</sup><italic toggle="yes">P</italic> = 0.021,</p>
                  </fn>
                  <fn id="T2Fn5">
                    <p><sup>b</sup><italic toggle="yes">P</italic> = 0.010,</p>
                  </fn>
                  <fn id="T2Fn6">
                    <p><sup>c</sup><italic toggle="yes">P</italic> = 0.001,</p>
                  </fn>
                  <fn id="T2Fn7">
                    <p><sup>d</sup><italic toggle="yes">P</italic> = 0.040,</p>
                  </fn>
                  <fn id="T2Fn8">
                    <p><sup>e</sup><italic toggle="yes">P</italic> = 0.011,</p>
                  </fn>
                  <fn id="T2Fn9">
                    <p><sup>f</sup><italic toggle="yes">P</italic> = 0.003.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <table-wrap position="float" id="T3">
                <label>Table 3.</label>
                <caption>
                  <p>Motility index of antral and duodenal pressure waves, and number, peak, and the time to peak number of isolated pyloric pressure following intragastric or intraduodenal administration of quinine in healthy men and women</p>
                </caption>
                <table frame="vsides" rules="groups">
                  <thead>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th colspan="3" rowspan="1">Male</th>
                      <th colspan="3" rowspan="1">Female</th>
                    </tr>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                      <th rowspan="1" colspan="1">IG-QHCl</th>
                      <th rowspan="1" colspan="1">ID-QHCl</th>
                      <th rowspan="1" colspan="1"><italic toggle="yes">P</italic> values</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Antral pressure waves</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>0-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">11 ± 1</td>
                      <td rowspan="1" colspan="1">10 ± 1</td>
                      <td rowspan="1" colspan="1">0.625</td>
                      <td rowspan="1" colspan="1">11 ± 1</td>
                      <td rowspan="1" colspan="1">11 ± 1</td>
                      <td rowspan="1" colspan="1">0.999</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>0-60min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">10 ± 1</td>
                      <td rowspan="1" colspan="1">8 ± 1</td>
                      <td rowspan="1" colspan="1">0.014</td>
                      <td rowspan="1" colspan="1">11 ± 1</td>
                      <td rowspan="1" colspan="1">11 ± 1<xref rid="T3Fn4" ref-type="table-fn"><sup>a</sup></xref></td>
                      <td rowspan="1" colspan="1">0.703</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>60-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">7 ± 1</td>
                      <td rowspan="1" colspan="1">7 ± 1</td>
                      <td rowspan="1" colspan="1">0.687</td>
                      <td rowspan="1" colspan="1">10 ± 1</td>
                      <td rowspan="1" colspan="1">9 ± 1<xref rid="T3Fn5" ref-type="table-fn"><sup>b</sup></xref></td>
                      <td rowspan="1" colspan="1">0.420</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Isolated pyloric pressure waves</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Total number<sub>0-120min</sub></td>
                      <td rowspan="1" colspan="1">25 ± 10</td>
                      <td rowspan="1" colspan="1">36 ± 11</td>
                      <td rowspan="1" colspan="1">0.426</td>
                      <td rowspan="1" colspan="1">16 ± 6</td>
                      <td rowspan="1" colspan="1">56 ± 15</td>
                      <td rowspan="1" colspan="1">0.002</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Total number<sub>0-60min</sub></td>
                      <td rowspan="1" colspan="1">11 ± 4</td>
                      <td rowspan="1" colspan="1">22 ± 8</td>
                      <td rowspan="1" colspan="1">0.050</td>
                      <td rowspan="1" colspan="1">6 ± 2</td>
                      <td rowspan="1" colspan="1">30 ± 9</td>
                      <td rowspan="1" colspan="1">0.013</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Total number<sub>60-120min</sub></td>
                      <td rowspan="1" colspan="1">14 ± 6</td>
                      <td rowspan="1" colspan="1">14 ± 4</td>
                      <td rowspan="1" colspan="1">0.451</td>
                      <td rowspan="1" colspan="1">9 ± 4</td>
                      <td rowspan="1" colspan="1">26 ± 9</td>
                      <td rowspan="1" colspan="1">0.039</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Peak number</td>
                      <td rowspan="1" colspan="1">7 ± 2</td>
                      <td rowspan="1" colspan="1">10 ± 2</td>
                      <td rowspan="1" colspan="1">0.356</td>
                      <td rowspan="1" colspan="1">6 ± 2</td>
                      <td rowspan="1" colspan="1">16 ± 3</td>
                      <td rowspan="1" colspan="1">0.001</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Time to peak number, min</td>
                      <td rowspan="1" colspan="1">70 ± 9</td>
                      <td rowspan="1" colspan="1">47 ± 10</td>
                      <td rowspan="1" colspan="1">0.173</td>
                      <td rowspan="1" colspan="1">90 ± 5</td>
                      <td rowspan="1" colspan="1">50 ± 8</td>
                      <td rowspan="1" colspan="1">0.008</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Mean amplitude<sub>0-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">18 ± 4</td>
                      <td rowspan="1" colspan="1">18 ± 3</td>
                      <td rowspan="1" colspan="1">0.345</td>
                      <td rowspan="1" colspan="1">21 ± 3</td>
                      <td rowspan="1" colspan="1">20 ± 2</td>
                      <td rowspan="1" colspan="1">0.333</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Mean amplitude<sub>0-60min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">21 ± 3</td>
                      <td rowspan="1" colspan="1">21 ± 4</td>
                      <td rowspan="1" colspan="1">0.533</td>
                      <td rowspan="1" colspan="1">20 ± 3</td>
                      <td rowspan="1" colspan="1">22 ± 3</td>
                      <td rowspan="1" colspan="1">0.451</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Mean amplitude<sub>60-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">21 ± 5</td>
                      <td rowspan="1" colspan="1">20 ± 3</td>
                      <td rowspan="1" colspan="1">0.613</td>
                      <td rowspan="1" colspan="1">24 ± 3</td>
                      <td rowspan="1" colspan="1">23 ± 3</td>
                      <td rowspan="1" colspan="1">0.517</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">
                        <bold>Duodenal pressure waves</bold>
                      </td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>0-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">15 ± 0</td>
                      <td rowspan="1" colspan="1">16 ± 0</td>
                      <td rowspan="1" colspan="1">0.404</td>
                      <td rowspan="1" colspan="1">15 ± 0</td>
                      <td rowspan="1" colspan="1">16 ± 0</td>
                      <td rowspan="1" colspan="1">0.032</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>0-60min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">13 ± 0</td>
                      <td rowspan="1" colspan="1">14 ± 0</td>
                      <td rowspan="1" colspan="1">0.042</td>
                      <td rowspan="1" colspan="1">14 ± 0</td>
                      <td rowspan="1" colspan="1">15 ± 0<xref rid="T3Fn6" ref-type="table-fn"><sup>c</sup></xref></td>
                      <td rowspan="1" colspan="1">0.007</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> MI<sub>60-120min</sub>, mmHg</td>
                      <td rowspan="1" colspan="1">14 ± 0</td>
                      <td rowspan="1" colspan="1">14 ± 0</td>
                      <td rowspan="1" colspan="1">0.835</td>
                      <td rowspan="1" colspan="1">15 ± 0</td>
                      <td rowspan="1" colspan="1">15 ± 0</td>
                      <td rowspan="1" colspan="1">0.242</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="T3Fn1">
                    <p>Data are means ± SEMs. n = 14 in each group.</p>
                  </fn>
                  <fn id="T3Fn2">
                    <p>Abbreviations: ID-QHCl, intraduodenal quinine hydrochloride; IG-QHCl, intragastric quinine hydrochloride; MI, motility index (calculated as MI (mmHg) = natural logarithm {[sum of amplitudes × number of pressure waves] + 1}).</p>
                  </fn>
                  <fn id="T3Fn3">
                    <p>Differences from respective values in males:</p>
                  </fn>
                  <fn id="T3Fn4">
                    <p><sup>a</sup><italic toggle="yes">P</italic> = 0.011,</p>
                  </fn>
                  <fn id="T3Fn5">
                    <p><sup>b</sup><italic toggle="yes">P</italic> = 0.045,</p>
                  </fn>
                  <fn id="T3Fn6">
                    <p><sup>c</sup>P = 0.017.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="s17">
                <title>Gut Hormones</title>
                <sec id="s18">
                  <title>Plasma ghrelin concentrations</title>
                  <p>While there were effects of time on plasma ghrelin after ID-QHCl, but not IG-QHCl, in both males (<italic toggle="yes">P</italic> = 0.034) and females (<italic toggle="yes">P</italic> = 0.035), and mean levels after ID-QHCl appeared to be lower compared with baseline, post hoc analysis revealed no differences (<xref rid="F1" ref-type="fig">Fig. 1A</xref>).</p>
                  <fig position="float" id="F1">
                    <label>Figure 1.</label>
                    <caption>
                      <p>Plasma concentrations of (A) ghrelin, (B) cholecystokinin (CCK), (C) peptide-YY (PYY) and (D) glucagon-like peptide-1 (GLP-1) following quinine hydrochloride (QHCl), administered (at t = −1 min) either intraduodenally (ID) or intragastrically (IG), in a dose of 600 mg, in 14 healthy men and 14 healthy women. One-way ANOVA was used to evaluate effects of treatments over time relative to baseline. (A) Time effects in * males (<italic toggle="yes">P</italic> = 0.034) and # females (<italic toggle="yes">P</italic> = 0.035) after ID-QHCl, (B) time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.004) after ID-QHCl, time effects in § males (<italic toggle="yes">P</italic> = 0.001) and α females (<italic toggle="yes">P</italic> = 0.024) after IG-QHCl, (C) time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.005) after ID-QHCl, (D) time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.010) after ID-QHCl. Data are means ± SEM at each sampling time point and expressed as changes from baseline.</p>
                    </caption>
                    <graphic xlink:href="dgac182_fig1" position="float"/>
                  </fig>
                  <p>There were effects of site on plasma ghrelin (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Fig. 1A</xref>). Ghrelin iAUCinv<sub>0-120,</sub> iAUCinv<sub>0-60</sub>, and iAUCinv<sub>60-120</sub> were greater after ID-QHCl compared with IG-QHCl in both males (iAUCinv<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.006, iAUCinv<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.019, iAUCinv<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.010) and females (iAUCinv<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.007, iAUCinv<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.013, iAUCinv<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.015).</p>
                </sec>
                <sec id="s19">
                  <title>Plasma CCK concentrations</title>
                  <p>There were effects of time on plasma CCK after ID-QHCl and IG-QHCl, with peak concentrations occurring within 20 to 30 minutes (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). Plasma CCK was greater after ID-QHCl compared with baseline, from t = 10 to 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001), and from t = 10 to 45 minutes and at t = 75 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.004). Moreover, plasma CCK was greater after IG-QHCl, compared with baseline, from t = 10 to 45 minutes and t = 75 to 90 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001), and from t = 10 to 30 minutes and at t = 60 and 120 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.024).</p>
                  <p>There were effects of site on plasma CCK (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Fig. 1B</xref>). CCK AUC<sub>0-120</sub> and AUC<sub>0-60</sub> were greater after ID-QHCl compared with IG-QHCl in males (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.002, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.006). Moreover, AUC<sub>0-60,</sub> but not AUC<sub>0-120</sub> or AUC<sub>60-120</sub>, was greater after ID-QHCl compared with IG-QHCl in females (AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.030). There were also effects of site on the peak CCK concentration, and the time to peak CCK concentration. Peak concentrations were greater (males: <italic toggle="yes">P</italic> = 0.01; females: <italic toggle="yes">P</italic> = 0.05), and times to peak concentration less (males: <italic toggle="yes">P</italic> = 0.02; females: <italic toggle="yes">P</italic> = 0.010), after ID-QHCl compared with IG-QHCl, in both males and females.</p>
                </sec>
                <sec id="s20">
                  <title>Plasma PYY concentrations</title>
                  <p>There were effects of time on plasma PYY after ID-QHCl, but not IG-QHCl (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Plasma PYY was greater after ID-QHCl, compared with baseline, between t = 30 and 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001), and at t = 60 and 120 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.005).</p>
                  <p>There were effects of site on plasma PYY (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Fig. 1C</xref>). PYY AUC<sub>0-120,</sub> AUC<sub>0-60</sub> and AUC<sub>60-120</sub> were greater after ID-QHCl compared with IG-QHCl in both males (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.017, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.010; AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.048) and females (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.013, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.022; AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.020).</p>
                </sec>
                <sec id="s21">
                  <title>Plasma GLP-1 concentrations</title>
                  <p>There were effects of time on plasma GLP-1 after ID-QHCl, but not IG-QHCl (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). Plasma GLP-1 was greater after ID-QHCl, compared with baseline, between t = 45 and 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001) and in females (time effect: <italic toggle="yes">P</italic> = 0.010).</p>
                  <p>There were effects of site on plasma GLP-1 (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Fig. 1D</xref>). GLP-1 AUC<sub>0-120,</sub> AUC<sub>0-60</sub>, and AUC<sub>60-120</sub> were greater after ID-QHCl compared with IG-QHCl in both males (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.025, AUC<sub>0-60:</sub><italic toggle="yes">P</italic> = 0.028, AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.040) and females (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.034, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.054, AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.046).</p>
                  <p>There were no effects of sex on plasma ghrelin, CCK, PYY, or GLP-1 after either IG-QHCl or ID-QHCl (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Figs. 1A-1D</xref>).</p>
                </sec>
              </sec>
              <sec id="s22">
                <title>Pancreatic Hormones and Plasma Glucose</title>
                <sec id="s23">
                  <title>Plasma insulin concentrations</title>
                  <p>There were effects of time on plasma insulin after ID-QHCl and IG-QHCl (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). Plasma insulin was greater after ID-QHCl compared with baseline, between t = 20 and 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001) and females (time effect: <italic toggle="yes">P</italic> = 0.001). Moreover, plasma insulin was greater after IG-QHCl, compared with baseline, between t = 45 and 75 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001), and between t = 60 and 120 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.010).</p>
                  <fig position="float" id="F2">
                    <label>Figure 2.</label>
                    <caption>
                      <p>Plasma concentrations of (A) insulin, (B) glucagon and (C) glucose following quinine hydrochloride (QHCl), administered (at t = −1 min) either intraduodenally (ID) or intragastrically (IG), in a dose of 600 mg, in 14 healthy men and 14 healthy women. One-way ANOVA was used to evaluate effects of treatments over time relative to baseline. (A) Time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.001) after ID-QHCl, time effects in § males (<italic toggle="yes">P</italic> = 0.001) and α females (<italic toggle="yes">P</italic> = 0.010) after IG-QHCl, (B) time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.001) after ID-QHCl, time effects in § males (<italic toggle="yes">P</italic> = 0.001) and α females (<italic toggle="yes">P</italic> = 0.002) after IG-QHCl, (C) time effects in * males (<italic toggle="yes">P</italic> = 0.001) and # females (<italic toggle="yes">P</italic> = 0.001) after ID-QHCl, time effects in § males (<italic toggle="yes">P</italic> = 0.016) and α females (<italic toggle="yes">P</italic> = 0.001) after IG-QHCl. Data are means ± SEM at each sampling time point and expressed as changes from baseline.</p>
                    </caption>
                    <graphic xlink:href="dgac182_fig2" position="float"/>
                  </fig>
                  <p>There were effects of site on plasma insulin (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2A</xref>). Insulin AUC<sub>0-120</sub> and AUC<sub>0-60</sub>, but not AUC<sub>60-120</sub>, were greater after ID-QHCl compared with IG-QHCl in both males (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.024, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.006) and females (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.004, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.001). There were also effects of site on peak insulin, and the time to peak insulin concentration. Peak concentrations were greater (males: <italic toggle="yes">P</italic> = 0.040; females: <italic toggle="yes">P</italic> = 0.002), and time to peak concentration less (males: <italic toggle="yes">P</italic> = 0.001; females: <italic toggle="yes">P</italic> = 0.012), after ID-QHCl compared with IG-QHCl in both males and females.</p>
                  <p>There were effects of sex on plasma insulin (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2A</xref>). Insulin AUC<sub>0-60</sub>, but not AUC<sub>0-120</sub> or AUC<sub>60-120</sub>, was greater in females than in males after ID-QHCl (AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.021), but not IG-QHCl. There was also an effect of sex on peak insulin, but not time to peak insulin concentration, after ID-QHCl, but not IG-QHCl. Peak concentration after ID-QHCl was greater in females compared with males (<italic toggle="yes">P</italic> = 0.01).</p>
                </sec>
                <sec id="s24">
                  <title>Plasma glucagon concentrations</title>
                  <p>There were effects of time on plasma glucagon after ID-QHCl and IG-QHCl (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). Plasma glucagon was greater after ID-QHCl between t = 60 and 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001) and females (time effect: <italic toggle="yes">P</italic> = 0.001), and after IG-QHCl in males (time effect: <italic toggle="yes">P</italic> = 0.001) and females (time effect: <italic toggle="yes">P</italic> = 0.002).</p>
                  <p>There were effects of site on plasma glucagon (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2B</xref>). Glucagon AUC<sub>0-120</sub>, AUC<sub>0-60</sub>, and AUC<sub>60-120</sub> were greater after ID-QHCl compared with IG-QHCl in both males (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.030, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.023, AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.043) and females (AUC<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.020, AUC<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.081, AUC<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.015).</p>
                  <p>There were no effects of sex on plasma glucagon after IG-QHCl or ID-QHCl (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2B</xref>).</p>
                </sec>
                <sec id="s25">
                  <title>Plasma glucose concentrations</title>
                  <p>There were effects of time on plasma glucose after ID-QHCl and IG-QHCl (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). Plasma glucose was less after ID-QHCl, compared with baseline, between t = 45 and 75 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.001) and between t = 30 and 120 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.001). Moreover, plasma glucose was less after IG-QHCl, compared with baseline, between t = 60 and 120 minutes in males (time effect: <italic toggle="yes">P</italic> = 0.016) and between t = 75 and 120 minutes in females (time effect: <italic toggle="yes">P</italic> = 0.001).</p>
                  <p>There were effects of site on plasma glucose (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2C</xref>). Plasma glucose iAUCinv<sub>0-120</sub>, iAUCinv<sub>0-60</sub>, and iAUCinv<sub>60-120</sub>, were greater after ID-QHCl compared with IG-QHCl in females (iAUCinv<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.001, iAUCinv<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.001, iAUCinv<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.036). In contrast, there were no differences after ID-QHCl compared with IG-QHCl in males.</p>
                  <p>There were effects of sex on plasma glucose (<xref rid="T2" ref-type="table">Table 2</xref>, <xref rid="F2" ref-type="fig">Fig. 2C</xref>). Plasma glucose iAUCinv<sub>0-120</sub>, iAUCinv<sub>0-60</sub>, and iAUCinv<sub>60-120</sub> were greater in females than in males after ID-QHCl (iAUCinv<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.001, iAUCinv<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.011, iAUCinv<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.003), while iAUCinv<sub>0-60</sub>, but not iAUCinv<sub>0-120</sub> or iAUCinv<sub>60-120</sub>, was less in females than in males after IG-QHCl (iAUCinv<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.04).</p>
                </sec>
              </sec>
              <sec id="s26">
                <title>Antropyloroduodenal Pressures</title>
                <sec id="s27">
                  <title>Antral pressures</title>
                  <p>There was an effect, albeit modest, of site on antral MI. Antral MI<sub>0-60</sub>, but not MI<sub>0-120</sub> or MI<sub>60-120</sub>, was greater after IG-QHCl compared with ID-QHCl in males (<italic toggle="yes">P</italic> = 0.014), but not in females (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
                  <p>There were effects, albeit modest, of sex on antral MI. Antral MI<sub>0-60</sub> (<italic toggle="yes">P</italic> = 0.011) and MI<sub>60-120</sub> (<italic toggle="yes">P</italic> = 0.045), but not MI<sub>0-120</sub>, were greater in females than in males after ID-QHCl but not IG-QHCl (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
                </sec>
                <sec id="s28">
                  <title>Isolated pyloric pressure waves</title>
                  <p>There were no effects of time on the number, or amplitude, of IPPWs after IG-QHCl or ID-QHCl in males or females (<xref rid="F3" ref-type="fig">Fig. 3</xref>). The IPPW response to ID-QHCl peaked between 15 and 45 minutes.</p>
                  <fig position="float" id="F3">
                    <label>Figure 3.</label>
                    <caption>
                      <p>Number of isolated pyloric pressure waves following quinine hydrochloride (QHCl), administered (at t = −1 min) either intraduodenally (ID) or intragastrically (IG), in a dose of 600 mg, in 14 healthy men and 14 healthy women. One-way ANOVA was used to evaluate effects of treatments over time relative to baseline. Data are means ± SEM for baseline (t = -1 to 0 min) and 15-min intervals following QHCl administration and expressed as changes from baseline.</p>
                    </caption>
                    <graphic xlink:href="dgac182_fig3" position="float"/>
                  </fig>
                  <p>There was an effect of site on the number, but not the amplitude, of IPPWs (<xref rid="T3" ref-type="table">Table 3</xref>, <xref rid="F3" ref-type="fig">Fig. 3</xref>). In females, IPPW number<sub>0-120</sub>, number<sub>0-60</sub>, and number<sub>60-120</sub> were greater after ID-QHCl compared with IG-QHCl (number<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.002, number<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.013, number<sub>60-120</sub>: <italic toggle="yes">P</italic> = 0.039). In males, IPPW number<sub>0-60</sub>, but not number<sub>0-120</sub> or number<sub>60-120</sub>, was greater after ID-QHCl compared with IG-QHCl (number<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.050). There were also effects of site on the peak number and the time to peak number of IPPWs. Peak number was greater (<italic toggle="yes">P</italic> = 0.001), and time to peak number less (<italic toggle="yes">P</italic> = 0.008), after ID-QHCl than IG-QHCl in females, but not males.</p>
                  <p>There were no effects of sex on the number or amplitude of IPPWs after IG-QHCl or ID-QHCl, although mean values appeared to be greater in females than males (<xref rid="T3" ref-type="table">Table 3</xref>, <xref rid="F3" ref-type="fig">Fig. 3</xref>).</p>
                </sec>
                <sec id="s29">
                  <title>Duodenal pressures</title>
                  <p>There were effects, albeit modest, of site on duodenal MI. In females, duodenal MI<sub>0-120</sub> and MI<sub>0-60</sub>, but not MI<sub>60-120</sub>, were greater after ID-QHCl compared with IG-QHCl (MI<sub>0-120</sub>: <italic toggle="yes">P</italic> = 0.032, MI<sub>0-60</sub>: <italic toggle="yes">P</italic> = 0.007). In males, the duodenal MI<sub>0-60</sub>, but not MI<sub>0-120</sub> and MI<sub>60-120</sub>, was greater after ID-QHCl compared with IG-QHCl (<italic toggle="yes">P</italic> = 0.042) (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
                  <p>There were effects, albeit modest, of sex on duodenal MI. The duodenal MI<sub>0-60</sub> was greater in females than in males after ID-QHCl (<italic toggle="yes">P</italic> = 0.017), and after IG-QHCl (<italic toggle="yes">P</italic> = 0.075). The duodenal MI<sub>60-120</sub> was also greater in females than in males after ID-QHCl (<italic toggle="yes">P</italic> = 0.061), but not IG-QHCl (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
                </sec>
              </sec>
              <sec id="s30">
                <title>GI Symptoms</title>
                <sec id="s31">
                  <title>Bloating</title>
                  <p>There were no effects of time, site, or sex on ratings of bloating after either IG-QHCl or ID-QHCl in males or females (<xref rid="F4" ref-type="fig">Fig. 4A</xref>).</p>
                  <fig position="float" id="F4">
                    <label>Figure 4.</label>
                    <caption>
                      <p>Scores for bloating (A) and nausea (B) following quinine hydrochloride (QHCl), administered (at t = -1 min) either intraduodenally (ID) or intragastrically (IG), in a dose of 600 mg, in 14 healthy men and 14 healthy women. One-way ANOVA was used to evaluate effects of treatments over time relative to baseline. Data are means ± SEM at each time point and expressed as changes from baseline.</p>
                    </caption>
                    <graphic xlink:href="dgac182_fig4" position="float"/>
                  </fig>
                </sec>
                <sec id="s32">
                  <title>Nausea</title>
                  <p>There were no effects of time on nausea after either IG-QHCl or ID-QHCl in males or females (<xref rid="F4" ref-type="fig">Fig. 4B</xref>).</p>
                  <p>There was an effect of site on nausea (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). In males, mean nausea was greater after ID-QHCl compared with IG-QHCl (<italic toggle="yes">P</italic> = 0.004). The slight increase in nausea was due to the ratings in 2 participants, which increased by ~40 mm, while no other participants reported any nausea.</p>
                  <p>There was an effect of sex on nausea (<xref rid="F4" ref-type="fig">Fig. 4B</xref>), which was greater in males than in females after ID-QHCl (<italic toggle="yes">P</italic> = 0.010), but not IG-QHCl.</p>
                </sec>
              </sec>
            </sec>
            <sec id="s33">
              <title>Discussion</title>
              <p>Our study provides a comprehensive evaluation of the comparative effects of IG and ID administration of QHCl, in a dose of 600 mg, on GI functions that are integral to the regulation of energy intake and blood glucose in healthy men and women, including gut and pancreatic hormones and pyloric pressures; the latter underlie the regulation of gastric emptying. Key findings are that (1) the effects of QHCl on gut and pancreatic hormones, glucose, and pyloric pressures were affected markedly by the site of its administration, with ID quinine being much more potent, and (2) the majority of these effects, with the exception of those relating to insulin and glucose, were not influenced by sex. These insights have important implications for an understanding of the factors modulating the effects of quinine, and probably other bitter substances, on GI functions.</p>
              <p>That ID-QHCl had greater effects to modulate gut and pancreatic hormones, reduce glucose and stimulate pyloric pressures, suggests that the regulation of these effects originates primarily in the small intestine. We have shown previously that ID- and IG-QHCl, when administered 30 minutes and 60 minutes, respectively, before a mixed-nutrient drink, have comparable effects to stimulate plasma GLP-1 (<xref rid="CIT0016" ref-type="bibr">16</xref>), suggesting that, in both situations, sufficient interaction of QHCl with small intestinal bitter receptors was achieved. Our current findings support this hypothesis and are also consistent with animal studies showing a greater density of bitter taste receptors in the duodenum than the stomach (<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0018" ref-type="bibr">18</xref>). Because quinine appears to be absorbed primarily in the small intestine (<xref rid="CIT0035" ref-type="bibr">35</xref>, <xref rid="CIT0036" ref-type="bibr">36</xref>), IG-QHCl also reaches the small intestine, although with a delay, and due to dilution, almost certainly in lower concentration than ID-QHCl. Moreover, a shorter length of intestine may be exposed following IG-QHCl. Both concentration and length of intestine exposed are known determinants of the effects of dietary nutrients on gut hormone release, gastric emptying, and energy intake (<xref rid="CIT0037" ref-type="bibr">37-39</xref>), and may underlie the more potent effects of ID vs IG-QHCl.</p>
              <p>Bitter taste receptors are present throughout the GI tract on enteroendocrine cells (<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0039" ref-type="bibr">39</xref>).</p>
              <p>CCK is produced primarily in the proximal small intestine, in contrast to GLP-1 and PYY, which are released predominantly more distally (<xref rid="CIT0040" ref-type="bibr">40</xref>, <xref rid="CIT0041" ref-type="bibr">41</xref>). Hence, the patterns of plasma concentrations of these hormones in response to quinine in the GI lumen would also be expected to vary. Accordingly, the rise in plasma CCK occurred within ~10 minutes and peaked within ~20-30 minutes. In contrast, the rises in GLP-1 and PYY were gradual and sustained for at least 120 minutes. These patterns of release are consistent with the effects of nutrients, such as fatty acids and protein (<xref rid="CIT0034" ref-type="bibr">34</xref>, <xref rid="CIT0042" ref-type="bibr">42</xref>). Of note, CCK, but not GLP-1 or PYY, was stimulated by IG-QHCl, albeit less than ID-QHCl, underscoring the importance of the length of exposure and that IG-QHCl may not readily reach the distal small intestine, the major site of release for GLP-1 and PYY. While ghrelin is primarily secreted from the stomach (<xref rid="CIT0041" ref-type="bibr">41</xref>), the observed greater suppression of plasma ghrelin after ID-QHCl, compared with IG-QHCl (which was ineffective), is indicative of an important contribution emanating from the small intestine. This is supported by the finding that small intestinal, but not gastric, exposure to nutrient (glucose) is sufficient to suppress plasma ghrelin (<xref rid="CIT0043" ref-type="bibr">43</xref>). The recent report of a lack of effect of ID- or IG-QHCl on either plasma CCK or ghrelin may reflect the lower dose used (<xref rid="CIT0017" ref-type="bibr">17</xref>), indicating dose-dependency. The suppressive effect of small intestinal nutrients or quinine on ghrelin release may, at least in part, be mediated by hormones. Intravenous infusions of CCK or PYY (<xref rid="CIT0003" ref-type="bibr">3-36</xref>) reduce plasma ghrelin levels in humans (<xref rid="CIT0044" ref-type="bibr">44-46</xref>); moreover, involvement of PYY may potentially underlie the continued suppression after 60 minutes.</p>
              <p>Both ID and IG-QHCl stimulated insulin; however, ID-QHCl was much more potent. While the mechanisms underlying quinine-induced stimulation of insulin remain to be elucidated, GLP-1 may potentially have played a role, which could be clarified by studies using a specific GLP-1 receptor antagonist. GLP-1-induced insulin secretion is known to be glucose-dependent—below a plasma glucose of 4.3 mmol/L, the insulinotropic effect of intravenous GLP-1, even at supraphysiological concentrations, is negligible (<xref rid="CIT0047" ref-type="bibr">47</xref>). Alternatively, quinine may stimulate insulin following absorption into the bloodstream by activating receptors on pancreatic beta cells directly. Preclinical studies have demonstrated quinine-induced insulin secretion from isolated pancreatic beta cells (<xref rid="CIT0048" ref-type="bibr">48</xref>). In our study, the rise in insulin was associated with subsequent reduction in plasma glucose by up to ~1.5 mmol/L, as well as stimulation of glucagon. Whether the observed rise in glucagon was a direct effect of quinine or triggered in response to glucose lowering, is uncertain, although the observed time course is more consistent with the concept that glucagon release followed the stimulation of insulin.</p>
              <p>The effect of quinine on pyloric pressures was also site-dependent, with ID more potent than IG administration. Given the key role of pyloric pressures in the regulation of gastric emptying (<xref rid="CIT0049" ref-type="bibr">49</xref>), this finding is consistent with our previous observations that IG quinine only slowed gastric emptying when it was given 60 minutes (<xref rid="CIT0016" ref-type="bibr">16</xref>), but not 30 minutes (<xref rid="CIT0013" ref-type="bibr">13</xref>), before a drink. Thus, these data provide compelling evidence for a key role of the small intestine in mediating the effects of quinine on pyloric motility. The pattern of pyloric pressures, with peak stimulation occurring during the first 15 to 45 minutes, reflected the pattern of CCK release. Since CCK receptors are located on pyloric smooth muscle cells (<xref rid="CIT0050" ref-type="bibr">50</xref>), the effect of quinine on pyloric pressures was likely mediated, at least in part, by endogenous CCK. Site-dependency of effects on antral and duodenal pressures was also evident, with a greater effect of IG quinine on antral, and a greater effect of ID quinine on duodenal, pressures, consistent with direct local effects of quinine on smooth muscle cells. Indeed, some bitter substances (e.g., denatonium benzoate, chloroquine) enhance motility by stimulating bitter taste receptors located on muscle strips of mouse antrum directly (<xref rid="CIT0001" ref-type="bibr">1</xref>). However, the magnitude of effects on antral and duodenal pressures in our study was small.</p>
              <p>The GI effects of bitter substances have been suggested to be sex-dependent, based on reports of greater perception of a bitter lingual stimulus (6-n-propylthiouracil) in females than males (<xref rid="CIT0019" ref-type="bibr">19</xref>, <xref rid="CIT0051" ref-type="bibr">51</xref>), although we did not find any differences in oral detection thresholds in our study. We have found inverse relationships between the oral perception of fatty acids and the magnitude of stimulation of pyloric pressures, CCK, and PYY in healthy individuals (<xref rid="CIT0052" ref-type="bibr">52</xref>). We observed greater effects in females than in males for quinine to stimulate insulin and lower plasma glucose, and modest effects to increase antral and duodenal motility, while no effects of sex on pyloric pressures or ghrelin were evident. Interestingly, a greater insulin response during an oral glucose tolerance test in healthy females, compared with males, has been reported, although in that study, and in contrast to the current findings, glucagon was suppressed more in males (<xref rid="CIT0053" ref-type="bibr">53</xref>). Since we found no significant evidence of sex effects on any of the GI hormones or pyloric pressures, our observations do not support the notion of major sex-dependent GI effects of quinine.</p>
              <p>Some limitations of our study should be noted. We only evaluated one dose of quinine, which was not adjusted for differences in body weight between men and women. We did not include a control condition and, thus, determined effects of quinine relative to baseline. However, infusion of isotonic saline is known to not affect the parameters we assessed (<xref rid="CIT0029" ref-type="bibr">29</xref>, <xref rid="CIT0033" ref-type="bibr">33</xref>, <xref rid="CIT0034" ref-type="bibr">34</xref>, <xref rid="CIT0042" ref-type="bibr">42</xref>). While ID or IG administration cannot be used routinely, the insights may be pivotal for the design of formulations for targeted delivery. We did not measure plasma motilin, which is modulated by bitter substances (<xref rid="CIT0014" ref-type="bibr">14</xref>, <xref rid="CIT0015" ref-type="bibr">15</xref>), although IG, but not ID, QHCl appears to suppress motilin (<xref rid="CIT0017" ref-type="bibr">17</xref>). We only assessed effects of quinine on fasting glucose; whether quinine lowers postprandial glucose in females more than in males warrants evaluation. Our findings should also be assessed as a function of age, body weight, race/ethnicity, and glucose tolerance status. The study was not powered for analysis of site of administration-by-sex interactions, so, potential synergistic effects between these factors were not assessed. Finally, it is important to recognize that quinine in higher doses may be associated with adverse effects, particularly in the longer-term, and also engage mechanisms other than bitter receptors, including sodium channel blockade. It is, therefore, important to determine whether the observed effects of quinine are also evident at lower doses.</p>
              <p>In conclusion, administration of quinine directly into the duodenum has much greater effects to modulate plasma gut and pancreatic hormones and pyloric pressures than intragastric administration, indicating the importance of the interaction of quinine with small intestinal bitter receptors. While our findings do not support the generalized concept of sex-dependent GI effects of quinine, the glucose-lowering effects of quinine appear to be enhanced in females. Taken together, our observations have implications for the use of targeted delivery options and potential for more personalized approaches for the administration of quinine, and possibly broadly, bitter substances, to optimize their potency to stimulate GI functions that modulate energy intake and blood glucose.</p>
            </sec>
          </body>
          <back>
            <ack id="a1">
              <title>Acknowledgments</title>
              <p>We thank Scott Standfield, Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, for performing the biochemical assays.</p>
            </ack>
            <glossary>
              <def-list>
                <title>Abbreviations</title>
                <def-item>
                  <term>ANOVA</term>
                  <def>
                    <p>analysis of variance</p>
                  </def>
                </def-item>
                <def-item>
                  <term>AUC</term>
                  <def>
                    <p>area under the curve</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CCK</term>
                  <def>
                    <p>cholecystokinin</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CV</term>
                  <def>
                    <p>coefficient of variation</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GI</term>
                  <def>
                    <p>gastrointestinal</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GLP-1</term>
                  <def>
                    <p>glucagon-like peptide-1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ID</term>
                  <def>
                    <p>intraduodenal</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IG</term>
                  <def>
                    <p>intragastric</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IPPW</term>
                  <def>
                    <p>isolated pyloric pressure wave</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MI</term>
                  <def>
                    <p>motility index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PYY</term>
                  <def>
                    <p>peptide YY (peptide tyrosine-tyrosine)</p>
                  </def>
                </def-item>
                <def-item>
                  <term>QHCl</term>
                  <def>
                    <p>quinine hydrochloride</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VAS</term>
                  <def>
                    <p>visual analog scale</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <sec id="s34">
              <title>Financial Support</title>
              <p>P.R. and V.B. were supported by an Adelaide Scholarship International, provided by the University of Adelaide (V.B., 2017-2020; P.R., 2018–2022) and C.F.B. by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (Grant 1103020, 2016–2022). The research was funded by an NHMRC Project Grant to C.F.B. (Grant 1158296, 2019–2022).</p>
            </sec>
            <sec id="s35">
              <title>Author Contributions</title>
              <p>C.F.B., P.R., B.R., and V.B. conceived and designed research; P.R. and B.R. performed experiments; J.F.R. performed the CCK radioimmunoassay, P.R. and K.L. analyzed the data; P.R., V.B., and C.F.B. interpreted the data; P.R. and C.F.B. drafted manuscript; P.R., B.R., V.B., M.H., J.F.R., and C.F.B. edited and revised manuscript; P.R., B.R., V.B., K.L., M.H., J.F.R., and C.F.B. approved the final version of manuscript.</p>
            </sec>
            <sec id="s36">
              <title>Conflict of Interest</title>
              <p>None of the authors have any conflicts of interest to declare.</p>
            </sec>
            <sec id="s37">
              <title>Clinical Trial Information</title>
              <p>The study was registered as a clinical trial with the Australian and New Zealand Clinical Trials Registry (<ext-link xlink:href="http://www.anzctr.org.au" ext-link-type="uri">www.anzctr.org.au</ext-link>; Registration ID: ACTRN12619000707167).</p>
            </sec>
            <sec sec-type="data-availability" id="s38">
              <title>Data Availability</title>
              <p>Some or all datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.</p>
            </sec>
            <ref-list id="r1">
              <title>References</title>
              <ref id="CIT0001">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Avau</surname><given-names>B</given-names></string-name>, <string-name><surname>Rotondo</surname><given-names>A</given-names></string-name>, <string-name><surname>Thijs</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group><article-title>Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation</article-title>. <source>Sci Rep.</source><year>2015</year>;<volume>5</volume>:<fpage>15985</fpage>.<pub-id pub-id-type="pmid">26541810</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0002">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janssen</surname><given-names>S</given-names></string-name>, <string-name><surname>Laermans</surname><given-names>J</given-names></string-name>, <string-name><surname>Verhulst</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Thijs</surname><given-names>T</given-names></string-name>, <string-name><surname>Tack</surname><given-names>J</given-names></string-name>, <string-name><surname>Depoortere</surname><given-names>I</given-names></string-name></person-group>. <article-title>Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying</article-title>. <source>Proc Natl Acad Sci USA.</source><year>2011</year>;<volume>108</volume>(<issue>5</issue>):<fpage>2094</fpage>-<lpage>2099</lpage>.<pub-id pub-id-type="pmid">21245306</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0003">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>KS</given-names></string-name>, <string-name><surname>Egan</surname><given-names>JM</given-names></string-name>, <string-name><surname>Jang</surname><given-names>HJ</given-names></string-name></person-group>. <article-title>Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways</article-title>. <source>Diabetologia.</source><year>2014</year>;<volume>57</volume>(<issue>10</issue>):<fpage>2117</fpage>-<lpage>2125</lpage>.<pub-id pub-id-type="pmid">25016595</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0004">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pham</surname><given-names>H</given-names></string-name>, <string-name><surname>Hui</surname><given-names>H</given-names></string-name>, <string-name><surname>Morvaridi</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group><article-title>A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2016</year>;<volume>475</volume>(<issue>3</issue>):<fpage>295</fpage>-<lpage>300</lpage>.<pub-id pub-id-type="pmid">27208775</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0005">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rezaie</surname><given-names>P</given-names></string-name>, <string-name><surname>Bitarafan</surname><given-names>V</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name></person-group>. <article-title>Effects of bitter substances on GI function, energy intake and glycaemia-so preclinical findings translate to outcomes in humans?</article-title><source>Nutrients.</source><year>2021</year>;<volume>13</volume>(<issue>4</issue>):<fpage>1317</fpage>.<pub-id pub-id-type="pmid">33923589</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0006">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>SV</given-names></string-name>, <string-name><surname>Rozengurt</surname><given-names>N</given-names></string-name>, <string-name><surname>Yang</surname><given-names>M</given-names></string-name>, <string-name><surname>Young</surname><given-names>SH</given-names></string-name>, <string-name><surname>Sinnett-Smith</surname><given-names>J</given-names></string-name>, <string-name><surname>Rozengurt</surname><given-names>E</given-names></string-name></person-group>. <article-title>Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells</article-title>. <source>Proc Natl Acad Sci USA.</source><year>2002</year>;<volume>99</volume>(<issue>4</issue>):<fpage>2392</fpage>-<lpage>2397</lpage>.<pub-id pub-id-type="pmid">11854532</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0007">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>MC</given-names></string-name>, <string-name><surname>Wu</surname><given-names>SV</given-names></string-name>, <string-name><surname>Reeve</surname><given-names>JR</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Rozengurt</surname><given-names>E</given-names></string-name></person-group>. <article-title>Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels</article-title>. <source>Am J Physiol Cell Physiol.</source><year>2006</year>;<volume>291</volume>(<issue>4</issue>):<fpage>C726</fpage>-<lpage>C739</lpage>.<pub-id pub-id-type="pmid">16707556</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0008">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Nevé</surname><given-names>B</given-names></string-name>, <string-name><surname>Foltz</surname><given-names>M</given-names></string-name>, <string-name><surname>Daniel</surname><given-names>H</given-names></string-name>, <string-name><surname>Gouka</surname><given-names>R</given-names></string-name></person-group>. <article-title>The steroid glycoside H.g.-12 from Hoodia gordonii activates the human bitter receptor TAS2R14 and induces CCK release from HuTu-80 cells</article-title>. <source>Am J Physiol Gastrointest Liver Physiol.</source><year>2010</year>;<volume>299</volume>(<issue>6</issue>):<fpage>G1368</fpage>-<lpage>G1375</lpage>.<pub-id pub-id-type="pmid">20930049</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0009">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Liszt</surname><given-names>KI</given-names></string-name>, <string-name><surname>Deloose</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group><article-title>Obesity alters adrenergic and chemosensory signaling pathways that regulate ghrelin secretion in the human gut</article-title>. <source>FASEB J.</source><year>2019</year>;<volume>33</volume>(<issue>4</issue>):<fpage>4907</fpage>-<lpage>4920</lpage>.<pub-id pub-id-type="pmid">30629462</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0010">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okitolonda</surname><given-names>W</given-names></string-name>, <string-name><surname>Delacollette</surname><given-names>C</given-names></string-name>, <string-name><surname>Malengreau</surname><given-names>M</given-names></string-name>, <string-name><surname>Henquin</surname><given-names>JC</given-names></string-name></person-group>. <article-title>High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria</article-title>. <source>Br Med J (Clin Res Ed).</source><year>1987</year>;<volume>295</volume>(<issue>6600</issue>):<fpage>716</fpage>-<lpage>718</lpage>.</mixed-citation>
              </ref>
              <ref id="CIT0011">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Henquin</surname><given-names>JC</given-names></string-name></person-group>. <article-title>Quinine and the stimulus-secretion coupling in pancreatic beta-cells: glucose-like effects on potassium permeability and insulin release</article-title>. <source>Endocrinol.</source><year>1982</year>;<volume>110</volume>(<issue>4</issue>):<fpage>1325</fpage>-<lpage>1332</lpage>.</mixed-citation>
              </ref>
              <ref id="CIT0012">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andreozzi</surname><given-names>P</given-names></string-name>, <string-name><surname>Sarnelli</surname><given-names>G</given-names></string-name>, <string-name><surname>Pesce</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects</article-title>. <source>J Neurogastroenterol Motil.</source><year>2015</year>;<volume>21</volume>(<issue>4</issue>):<fpage>511</fpage>-<lpage>519</lpage>.<pub-id pub-id-type="pmid">26351252</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0013">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bitarafan</surname><given-names>V</given-names></string-name>, <string-name><surname>Fitzgerald</surname><given-names>PCE</given-names></string-name>, <string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <etal>et al</etal></person-group><article-title>Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source><year>2020</year>;<volume>318</volume>(<issue>2</issue>): 
<fpage>R263</fpage>-<lpage>R273</lpage>.<pub-id pub-id-type="pmid">31774306</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0014">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deloose</surname><given-names>E</given-names></string-name>, <string-name><surname>Corsetti</surname><given-names>M</given-names></string-name>, <string-name><surname>Van Oudenhove</surname><given-names>L</given-names></string-name>, <string-name><surname>Depoortere</surname><given-names>I</given-names></string-name>, <string-name><surname>Tack</surname><given-names>J</given-names></string-name></person-group>. <article-title>Intragastric infusion of the bitter tastant quinine suppresses hormone release and antral motility during the fasting state in healthy female volunteers</article-title>. <source>J Neurogastroenterol Motil.</source><year>2018</year>;<volume>30</volume>(<issue>1</issue>):<fpage>e13171</fpage>.</mixed-citation>
              </ref>
              <ref id="CIT0015">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iven</surname><given-names>J</given-names></string-name>, <string-name><surname>Biesiekierski</surname><given-names>JR</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group><article-title>Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms</article-title>. <source>Nutr Neurosci.</source><year>2019</year>;<volume>22</volume>(<issue>12</issue>):<fpage>850</fpage>-<lpage>862</lpage>.<pub-id pub-id-type="pmid">29607741</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0016">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rose</surname><given-names>BD</given-names></string-name>, <string-name><surname>Bitarafan</surname><given-names>V</given-names></string-name>, <string-name><surname>Rezaie</surname><given-names>P</given-names></string-name>, <string-name><surname>Fitzgerald</surname><given-names>PCE</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name></person-group>. <article-title>Comparative effects of intragastric and intraduodenal administration of quinine on the plasma glucose response to a mixed-nutrient drink in healthy men: relations with glucoregulatory hormones and gastric emptying</article-title>. <source>J Nutr.</source><year>2021</year>;<volume>151</volume>(<issue>6</issue>):<fpage>1453</fpage>-<lpage>1461</lpage>.<pub-id pub-id-type="pmid">33704459</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0017">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verbeure</surname><given-names>W</given-names></string-name>, <string-name><surname>Deloose</surname><given-names>E</given-names></string-name>, <string-name><surname>Tóth</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group><article-title>The endocrine effects of bitter tastant administration in the gastrointestinal system: intragastric versus intraduodenal administration</article-title>. <source>Am J Physiol Endocrinol Metab.</source><year>2021</year>;<volume>321</volume>(<issue>1</issue>):<fpage>E1</fpage>-<lpage>E10</lpage>.<pub-id pub-id-type="pmid">34029163</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0018">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Imai</surname><given-names>H</given-names></string-name>, <string-name><surname>Hakukawa</surname><given-names>M</given-names></string-name>, <string-name><surname>Hayashi</surname><given-names>M</given-names></string-name>, <string-name><surname>Iwatsuki</surname><given-names>K</given-names></string-name>, <string-name><surname>Masuda</surname><given-names>K</given-names></string-name></person-group>. <article-title>Expression of bitter taste receptors in the intestinal cells of non-human primates</article-title>. <source>Int J Mol Sci.</source><year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>902</fpage>.</mixed-citation>
              </ref>
              <ref id="CIT0019">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartoshuk</surname><given-names>LM</given-names></string-name>, <string-name><surname>Duffy</surname><given-names>VB</given-names></string-name>, <string-name><surname>Miller</surname><given-names>IJ</given-names></string-name></person-group>. <article-title>PTC/PROP tasting: anatomy, psychophysics, and sex effects</article-title>. <source>Physiol Behav.</source><year>1994</year>;<volume>56</volume>(<issue>6</issue>):<fpage>1165</fpage>-<lpage>1171</lpage>.<pub-id pub-id-type="pmid">7878086</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0020">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deloose</surname><given-names>E</given-names></string-name>, <string-name><surname>Janssen</surname><given-names>P</given-names></string-name>, <string-name><surname>Corsetti</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Intragastric infusion of denatonium benzoate attenuates interdigestive gastric motility and hunger scores in healthy female volunteers</article-title>. <source>Am J Clin Nutr</source>. <year>2017</year>;<volume>105</volume>(<issue>3</issue>):<fpage>580</fpage>-<lpage>588</lpage>.<pub-id pub-id-type="pmid">28148502</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0021">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steinert</surname><given-names>RE</given-names></string-name>, <string-name><surname>Luscombe-Marsh</surname><given-names>ND</given-names></string-name>, <string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men</article-title>. <source>J Clin Endocrinol Metab.</source><year>2014</year>;<volume>99</volume>(<issue>9</issue>):<fpage>3275</fpage>-<lpage>3284</lpage>.<pub-id pub-id-type="pmid">24926954</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0022">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stunkard</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Messick</surname><given-names>S</given-names></string-name></person-group>. <article-title>The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger</article-title>. <source>J Psychosom Res.</source><year>1985</year>;<volume>29</volume>(<issue>1</issue>):<fpage>71</fpage>-<lpage>83</lpage>.<pub-id pub-id-type="pmid">3981480</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0023">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chalé-Rush</surname><given-names>A</given-names></string-name>, <string-name><surname>Burgess</surname><given-names>JR</given-names></string-name>, <string-name><surname>Mattes</surname><given-names>RD</given-names></string-name></person-group>. <article-title>Evidence for human orosensory (taste?) sensitivity to free fatty acids</article-title>. <source>Chem Senses.</source><year>2007</year>;<volume>32</volume>(<issue>5</issue>):<fpage>423</fpage>-<lpage>431</lpage>.<pub-id pub-id-type="pmid">17361006</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0024">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brennan</surname><given-names>IM</given-names></string-name>, <string-name><surname>Feltrin</surname><given-names>KL</given-names></string-name>, <string-name><surname>Nair</surname><given-names>NS</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women</article-title>. <source>Am J Physiol Gastrointest Liver Physiol.</source><year>2009</year>;<volume>297</volume>(<issue>3</issue>):<fpage>G602</fpage>-<lpage>G610</lpage>.<pub-id pub-id-type="pmid">19556358</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0025">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steinert</surname><given-names>RE</given-names></string-name>, <string-name><surname>Landrock</surname><given-names>MF</given-names></string-name>, <string-name><surname>Ullrich</surname><given-names>SS</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of intraduodenal infusion of the branched-chain amino acid leucine on ad libitum eating, gut motor and hormone functions, and glycemia in healthy men</article-title>. <source>Am J Clin Nutr.</source><year>2015</year>;<volume>102</volume>(<issue>4</issue>):<fpage>820</fpage>-<lpage>827</lpage>.<pub-id pub-id-type="pmid">26289436</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0026">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heddle</surname><given-names>R</given-names></string-name>, <string-name><surname>Dent</surname><given-names>J</given-names></string-name>, <string-name><surname>Toouli</surname><given-names>J</given-names></string-name>, <string-name><surname>Read</surname><given-names>NW</given-names></string-name></person-group>. <article-title>Topography and measurement of pyloric pressure waves and tone in humans</article-title>. <source>Am J Physiol.</source><year>1988</year>;<volume>255</volume>(<issue>4 Pt 1</issue>):<fpage>G490</fpage>-<lpage>G497</lpage>.<pub-id pub-id-type="pmid">3140675</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0027">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehfeld</surname><given-names>JF</given-names></string-name></person-group>. <article-title>Accurate measurement of cholecystokinin in plasma</article-title>. <source>Clin Chem.</source><year>1998</year>;<volume>44</volume>(<issue>5</issue>):<fpage>991</fpage>-<lpage>1001</lpage>.<pub-id pub-id-type="pmid">9590372</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0028">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pilichiewicz</surname><given-names>AN</given-names></string-name>, <string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Brennan</surname><given-names>IM</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source><year>2006</year>;<volume>290</volume>(<issue>3</issue>):<fpage>R668</fpage>-<lpage>R677</lpage>.<pub-id pub-id-type="pmid">16210415</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0029">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feltrin</surname><given-names>KL</given-names></string-name>, <string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>JH</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans</article-title>. <source>J Physiol.</source><year>2007</year>;<volume>581</volume>(<issue>Pt 2</issue>):<fpage>767</fpage>-<lpage>777</lpage>.<pub-id pub-id-type="pmid">17331985</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0030">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heddle</surname><given-names>R</given-names></string-name>, <string-name><surname>Dent</surname><given-names>J</given-names></string-name>, <string-name><surname>Read</surname><given-names>NW</given-names></string-name>, <etal>et al</etal></person-group><article-title>Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers</article-title>. <source>Am J Physiol.</source><year>1988</year>;<volume>254</volume>(<issue>5 Pt 1</issue>):<fpage>G671</fpage>-<lpage>G679</lpage>.<pub-id pub-id-type="pmid">3364568</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0031">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camilleri</surname><given-names>M</given-names></string-name>, <string-name><surname>Malagelada</surname><given-names>JR</given-names></string-name></person-group>. <article-title>Abnormal intestinal motility in diabetics with the gastroparesis syndrome</article-title>. <source>Eur J Clin Invest.</source><year>1984</year>;<volume>14</volume>(<issue>6</issue>):<fpage>420</fpage>-<lpage>427</lpage>.<pub-id pub-id-type="pmid">6441717</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0032">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feltrin</surname><given-names>KL</given-names></string-name>, <string-name><surname>Patterson</surname><given-names>M</given-names></string-name>, <string-name><surname>Ghatei</surname><given-names>MA</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men</article-title>. <source>Peptides.</source><year>2006</year>;<volume>27</volume>(<issue>7</issue>):<fpage>1638</fpage>-<lpage>1643</lpage>.<pub-id pub-id-type="pmid">16563563</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0033">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McVeay</surname><given-names>C</given-names></string-name>, <string-name><surname>Fitzgerald</surname><given-names>PCE</given-names></string-name>, <string-name><surname>Ullrich</surname><given-names>SS</given-names></string-name>, <string-name><surname>Steinert</surname><given-names>RE</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name></person-group>. <article-title>Effects of intraduodenal administration of lauric acid and L-tryptophan, alone and combined, on gut hormones, pyloric pressures, and energy intake in healthy men</article-title>. <source>Am J Clin Nutr.</source><year>2019</year>;<volume>109</volume>(<issue>5</issue>):<fpage>1335</fpage>-<lpage>1343</lpage>.<pub-id pub-id-type="pmid">31051504</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0034">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ryan</surname><given-names>AT</given-names></string-name>, <string-name><surname>Luscombe-Marsh</surname><given-names>ND</given-names></string-name>, <string-name><surname>Saies</surname><given-names>AA</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men</article-title>. <source>Am J Clin Nutr.</source><year>2013</year>;<volume>98</volume>(<issue>2</issue>):<fpage>300</fpage>-<lpage>311</lpage>.<pub-id pub-id-type="pmid">23803895</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0035">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hogben</surname><given-names>CA</given-names></string-name>, <string-name><surname>Tocco</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Brodie</surname><given-names>BB</given-names></string-name>, <string-name><surname>Schanker</surname><given-names>LS</given-names></string-name></person-group>. <article-title>On the mechanism of intestinal absorption of drugs</article-title>. <source>J Pharmacol Exp Ther.</source><year>1959</year>;<volume>125</volume>(<issue>4</issue>):<fpage>275</fpage>-<lpage>282</lpage>.<pub-id pub-id-type="pmid">13642268</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0036">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murakami</surname><given-names>M</given-names></string-name>, <string-name><surname>Takada</surname><given-names>K</given-names></string-name>, <string-name><surname>Muranishi</surname><given-names>S</given-names></string-name></person-group>. <article-title>Further mechanistic study on intestinal absorption enhanced by unsaturated fatty acids: reversible effect by sulfhydryl modification</article-title>. <source>Biochim Biophys Acta.</source><year>1992</year>;<volume>1117</volume>(<issue>1</issue>):<fpage>83</fpage>-<lpage>89</lpage>.<pub-id pub-id-type="pmid">1627597</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0037">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>HC</given-names></string-name>, <string-name><surname>Doty</surname><given-names>JE</given-names></string-name>, <string-name><surname>Reedy</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>JH</given-names></string-name></person-group>. <article-title>Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient</article-title>. <source>Am J Physiol.</source><year>1989</year>;<volume>256</volume>(<issue>2 Pt 1</issue>):<fpage>G404</fpage>-<lpage>G411</lpage>.<pub-id pub-id-type="pmid">2919683</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0038">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Doran</surname><given-names>S</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>JH</given-names></string-name>, <etal>et al</etal></person-group><article-title>The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed</article-title>. <source>Am J Physiol Endocrinol Metab.</source><year>2006</year>;<volume>291</volume>(<issue>3</issue>):<fpage>E647</fpage>-<lpage>E655</lpage>.<pub-id pub-id-type="pmid">16684852</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0039">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>JH</given-names></string-name>, <string-name><surname>Hlinka</surname><given-names>M</given-names></string-name>, <string-name><surname>Tabrizi</surname><given-names>Y</given-names></string-name>, <string-name><surname>DiMaso</surname><given-names>N</given-names></string-name>, <string-name><surname>Raybould</surname><given-names>HE</given-names></string-name></person-group>. <article-title>Chemical specificities and intestinal distributions of nutrient-driven satiety</article-title>. <source>Am J Physiol.</source><year>1998</year>;<volume>275</volume>(<issue>4</issue>):<fpage>R1293</fpage>-<lpage>R1307</lpage>.<pub-id pub-id-type="pmid">9756563</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0040">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gribble</surname><given-names>FM</given-names></string-name>, <string-name><surname>Reimann</surname><given-names>F</given-names></string-name></person-group>. <article-title>Function and mechanisms of enteroendocrine cells and gut hormones in metabolism</article-title>. <source>Nat Rev Endocrinol.</source><year>2019</year>;<volume>15</volume>(<issue>4</issue>):<fpage>226</fpage>-<lpage>237</lpage>.<pub-id pub-id-type="pmid">30760847</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0041">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steinert</surname><given-names>RE</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name>, <string-name><surname>Asarian</surname><given-names>L</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Beglinger</surname><given-names>C</given-names></string-name>, <string-name><surname>Geary</surname><given-names>N</given-names></string-name></person-group>. <article-title>Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB</article-title>. <source>Physiol Rev.</source><year>2017</year>;<volume>97</volume>(<issue>1</issue>):<fpage>411</fpage>-<lpage>463</lpage>.<pub-id pub-id-type="pmid">28003328</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0042">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Little</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Feltrin</surname><given-names>KL</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source><year>2005</year>;<volume>289</volume>(<issue>4</issue>):<fpage>R1090</fpage>-<lpage>R1098</lpage>.<pub-id pub-id-type="pmid">15961531</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0043">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parker</surname><given-names>BA</given-names></string-name>, <string-name><surname>Doran</surname><given-names>S</given-names></string-name>, <string-name><surname>Wishart</surname><given-names>J</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>IM</given-names></string-name></person-group>. <article-title>Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women</article-title>. <source>Clin Endocrinol (Oxf).</source><year>2005</year>;<volume>62</volume>(<issue>5</issue>):<fpage>539</fpage>-<lpage>546</lpage>.<pub-id pub-id-type="pmid">15853822</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0044">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Batterham</surname><given-names>RL</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>MA</given-names></string-name>, <string-name><surname>Ellis</surname><given-names>SM</given-names></string-name>, <etal>et al</etal></person-group><article-title>Inhibition of food intake in obese subjects by peptide YY3-36</article-title>. <source>N Engl J Med.</source><year>2003</year>;<volume>349</volume>(<issue>10</issue>):<fpage>941</fpage>-<lpage>948</lpage>.<pub-id pub-id-type="pmid">12954742</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0045">
                <label>45.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brennan</surname><given-names>IM</given-names></string-name>, <string-name><surname>Otto</surname><given-names>B</given-names></string-name>, <string-name><surname>Feltrin</surname><given-names>KL</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>JH</given-names></string-name>, <string-name><surname>Horowitz</surname><given-names>M</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name></person-group>. <article-title>Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men</article-title>. <source>Peptides.</source><year>2007</year>;<volume>28</volume>(<issue>3</issue>):<fpage>607</fpage>-<lpage>611</lpage>.<pub-id pub-id-type="pmid">17129639</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0046">
                <label>46.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Degen</surname><given-names>L</given-names></string-name>, <string-name><surname>Oesch</surname><given-names>S</given-names></string-name>, <string-name><surname>Casanova</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effect of peptide YY3-36 on food intake in humans</article-title>. <source>Gastroenterology.</source><year>2005</year>;<volume>129</volume>(<issue>5</issue>):<fpage>1430</fpage>-<lpage>1436</lpage>.<pub-id pub-id-type="pmid">16285944</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0047">
                <label>47.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nauck</surname><given-names>MA</given-names></string-name>, <string-name><surname>Heimesaat</surname><given-names>MM</given-names></string-name>, <string-name><surname>Behle</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group><article-title>Effects of glucagon-like peptide-1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers</article-title>. <source>J Clin Endocrinol Metab.</source><year>2002</year>;<volume>87</volume>(<issue>3</issue>):<fpage>1239</fpage>-<lpage>1246</lpage>.<pub-id pub-id-type="pmid">11889194</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0048">
                <label>48.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Henquin</surname><given-names>JC</given-names></string-name>, <string-name><surname>Horemans</surname><given-names>B</given-names></string-name>, <string-name><surname>Nenquin</surname><given-names>M</given-names></string-name>, <string-name><surname>Verniers</surname><given-names>J</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>AE</given-names></string-name></person-group>. <article-title>Quinine-induced modifications of insulin release and glucose metabolism by isolated pancreatic islets</article-title>. <source>FEBS Lett.</source><year>1975</year>;<volume>57</volume>(<issue>3</issue>):<fpage>280</fpage>-<lpage>284</lpage>.<pub-id pub-id-type="pmid">1102333</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0049">
                <label>49.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Houghton</surname><given-names>LA</given-names></string-name>, <string-name><surname>Read</surname><given-names>NW</given-names></string-name>, <string-name><surname>Heddle</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group><article-title>Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal</article-title>. <source>Gastroenterology.</source><year>1988</year>;<volume>94</volume>(<issue>6</issue>):<fpage>1285</fpage>-<lpage>1291</lpage>.<pub-id pub-id-type="pmid">3360256</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0050">
                <label>50.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>GT</given-names></string-name>, <string-name><surname>Moran</surname><given-names>TH</given-names></string-name>, <string-name><surname>Coyle</surname><given-names>JT</given-names></string-name>, <string-name><surname>Kuhar</surname><given-names>MJ</given-names></string-name>, <string-name><surname>O’Donahue</surname><given-names>TL</given-names></string-name>, <string-name><surname>McHugh</surname><given-names>PR</given-names></string-name></person-group>. <article-title>Anatomic localization of cholecystokinin receptors to the pyloric sphincter</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source><year>1984</year>;<volume>246</volume>(<issue>1</issue>):<fpage>R127</fpage>-<lpage>R130</lpage>.</mixed-citation>
              </ref>
              <ref id="CIT0051">
                <label>51.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garneau</surname><given-names>NL</given-names></string-name>, <string-name><surname>Nuessle</surname><given-names>TM</given-names></string-name>, <string-name><surname>Sloan</surname><given-names>MM</given-names></string-name>, <string-name><surname>Santorico</surname><given-names>SA</given-names></string-name>, <string-name><surname>Coughlin</surname><given-names>BC</given-names></string-name>, <string-name><surname>Hayes</surname><given-names>JE</given-names></string-name></person-group>. <article-title>Crowdsourcing taste research: genetic and phenotypic predictors of bitter taste perception as a model</article-title>. <source>Front Integr Neurosci.</source><year>2014</year>;<volume>8</volume>:<fpage>33</fpage>.<pub-id pub-id-type="pmid">24904324</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0052">
                <label>52.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stewart</surname><given-names>JE</given-names></string-name>, <string-name><surname>Seimon</surname><given-names>RV</given-names></string-name>, <string-name><surname>Otto</surname><given-names>B</given-names></string-name>, <string-name><surname>Keast</surname><given-names>RS</given-names></string-name>, <string-name><surname>Clifton</surname><given-names>PM</given-names></string-name>, <string-name><surname>Feinle-Bisset</surname><given-names>C</given-names></string-name></person-group>. <article-title>Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men</article-title>. <source>Am J Clin Nutr.</source><year>2011</year>;<volume>93</volume>(<issue>4</issue>):<fpage>703</fpage>-<lpage>711</lpage>.<pub-id pub-id-type="pmid">21310831</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0053">
                <label>53.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horie</surname><given-names>I</given-names></string-name>, <string-name><surname>Abiru</surname><given-names>N</given-names></string-name>, <string-name><surname>Eto</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group><article-title>Sex differences in insulin and glucagon responses for glucose homeostasis in young healthy Japanese adults</article-title>. <source>J Diabetes Investig.</source><year>2018</year>;<volume>9</volume>(<issue>6</issue>):<fpage>1283</fpage>-<lpage>1287</lpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
